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ABSTRACT
AAA+ self-compartmentalized proteases are an important class of proteome regulators that
operate to selectively degrade protein substrates. All of these enzymes share the
architectural theme of a hexameric ring unfoldase stacked axially onto a barrel-like
peptidase, with six- or seven-fold symmetry and sequestered active sites. ClpXP is a model
self-compartmentalized protease composed of the regulator ClpX and the serine protease
ClpP. Proteolysis occurs by ClpX-dependent substrate selection, unfolding, and
translocation into the degradation lumen of ClpP, where rapid and relatively non-specific
peptide hydrolysis generates small peptide products.
Prior work had shown that ClpP is unable to degrade polypeptides in the absence of ClpX,
suggesting the existence of a mechanism that inhibits the activity of free ClpP. Structures of
free ClpP show active sites geometrically competent to perform peptide-hydrolysis
chemistry. However, some biochemical results suggested that N-terminal ClpP residues,
which line the axial entrance pores, allosterically regulate these active sites. Through
measurements of ClpP active-site reactivity, degradation of size-varied peptides, and
mutagenesis of the N-termini, I found that peptide degradation is inhibited by steric
occlusion, maintained by the N-terminal 3-stem loop and a-helix A of ClpP. The N-termini
also participate in specifying substrate choice, as mutations within the axial channel prevent
degradation of peptides containing stretches of charged amino acids. These data support a
model in which ClpX binding opens the axial pore of ClpP to facilitate polypeptide
translocation.
Additional residues in ClpP that are important for its function were identified by a selection
for dominant-negative mutants impaired in ClpXP-dependent proteolysis. Biochemical
studies and mapping of these mutations onto the structure of ClpP suggest that these variants
are defective in tetradecamer assembly, peptide binding at the active sites, and ClpX
binding. This work provides a foundation for further investigations of the mechanisms of
ClpP assembly, degradation, and interactions with ClpX.
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CHAPTER ONE:
Introduction
REGULATED PROTEOLYSIS: FUNCTIONAL SIGNIFICANCE AND
REGULATORY MOTIFS
Protein degradation is a key biological process. Initially considered of low biological
significance because of the metabolically costly nature of protein synthesis (Wolf 2004),
proteolysis is now recognized for its importance in many biological functions, including
controlling intracellular protein quality, facilitating rapid responses to external stress factors,
and advancing through the cell cycle. The enzymes that catalyze protein degradation -
proteases - are exquisitely controlled at multiple levels: gene expression, intracellular
localization, cofactor binding, and substrate specificity. In aggregate, these mechanisms for
regulating protease activity allow fine-tuning of the proteome, promoting survival in many
growth extremes.
Proteases control intracellular protein quality by removing damaged, misfolded, or
aggregated proteins. In collaboration with chaperones that encourage protein refolding, the
action of proteases limits the intracellular concentrations of damaged proteins that could be
deleterious for the cell (Wickner et al. 1999). As an example, the endoplasmic reticulum
(ER) has evolved an intricate surveillance mechanism to check the quality of the proteins
that need to fold within this organelle (Vembar et al. 2008). This mechanism, termed ER-
associated degradation, ensures that proteins which cannot be folded by ER chaperones are
retro-translocated to the cytoplasm, where they are degraded.
Unfolded or misfolded polypeptides are typically highly sensitive to degradation, either
because the polypeptide backbone is exposed to non-specific proteases or because specific
sequences in the denatured protein target it to a specific protease (see below). In addition,
almost all cellular compartments contain proteases, and thus proteolysis competes
kinetically with protein folding. Because of mistakes during translation on the ribosome,
some proteins cannot fold stably and appear to be rapidly proteolyzed immediately after
synthesis. Some estimates indicate that proteolysis targets about 20% of newly synthesized
proteins (Wickner et al. 1999). In other cases, oxidation or other types of chemical
modification may lead to irreversible protein unfolding. Degradation of proteins that cannot
fold or that fold too slowly allows recycling of their amino acids and prevents formation of
aggregates, which under some circumstances can be toxic (Turner et al. 2000).
In bacteria, rapid cellular responses to external stresses such as heat or osmotic shock are
required for survival and are frequently regulated by proteolysis. In general, these responses
involve transcription factors that upregulate the expression of gene products that are needed
to combat the negative effects of environmental stress. There are multiple strategies by
which proteolysis can control transcription-factor activity. In E. coli, for example, the
expression of heat-shock proteins is controlled by the &32 transcription factor (Guisbert et al.
2008). This factor is constitutively synthesized but is rapidly degraded with a half life of -1
min under normal growth conditions. Following heat shock, degradation of Q 32 slows
(perhaps because other substrates produced by thermal denaturation compete for
proteolysis), resulting in an increase in steady-state levels and enhanced expression of heat-
shock genes (Herman et al. 1995). In another example, the oE transcription factor controls
expression of genes required to respond to stress in the periplasm or cell envelope (Ades
2004). In this case, oE is normally inhibited by binding to a membrane-bound anti-sigma
factor. When protein folding in the periplasm is compromised, a series of proteolytic
cleavages destroy this anti-sigma factor, freeing oE to activate gene expression.
Proteolysis is also important for temporal coordination of cellular events. For example,
degradation of multiple proteins is required for eukaryotic cells to progress through the cell
cycle. In this process, degradation of different cyclin proteins controls the activity window
of associated cyclin-dependent kinases, allowing precisely-timed phosphorylation of target
proteins crucial for cell-cycle progression (Nakayama et al. 2006). Additionally, the
transition from metaphase to anaphase requires segregation of sister chromatids, a process
made possible by the degradation of cohesin-ring proteins (Nasmyth 2005). Proteolysis also
regulates the cell cycle in some prokaryotes. In Caulobacter crescentus, for example,
degradation of CtrA, a master transcription factor and cell-cycle regulator, allows initiation
of DNA replication and triggers transcription of genes required for cell-cycle progression
(Biondi et al. 2006; Brown et al. 2009).
As illustrated by the examples discussed so far, proteolysis is important for the elimination
of misfolded or damaged proteins and for the regulation of many cellular processes.
However, these destructive proteolytic events must take place in a cellular environment that
contains thousands of other types of proteins, which need to be spared from degradation.
Given the injurious consequences of rogue degradation, numerous mechanisms exist to
regulate intracellular proteolysis (Holzer et al. 1980). Some proteases are sequestered in
specialized organelles, such as vacuoles or lysosomes, or are only expressed under specific
circumstances (Brown et al. 2000; Wolf 2004; Pop et al. 2009). Other proteases are
synthesized as inactive proenzymes that require activation. For example, the apoptotic
executioner pro-caspases are activated via endoproteoyolic cleavage by initator caspases
(Pop et al. 2009). Cofactor binding is required for certain proteolytic events. For example,
the SOS LexA repressor is an autoprotease but only cleaves itself when bound in a complex
with RecA and single-stranded DNA (Little 1991). Similarly, the periplasmic DegS
protease is only activated when specific peptides bind to its PDZ domain (Walsh et al.
2003). One of the most prevalent forms of proteolytic regulation occurs at the level of
substrate recognition (Baker et al. 2006; Schrader et al. 2009). For example, the eukaryotic
proteasome recognizes substrates that have been modified by addition of poly-ubiquitin
chains. In bacteria, proteasome-like enzymes generally recognize specific peptide
sequences in substrate proteins. Many intracellular proteases are regulated via several of
these mechanisms, emphasizing the importance of controlling degradation activity.
SELF-COMPARTMENTALIZED PROTEASES
A common mechanism of controlling the activity of intracellular proteases is to place the
active sites for peptide-bond cleavage in a sequestered chamber and then to regulate the
access of substrates to this compartment (Baker et al. 2006; Striebel et al. 2009). Self-
compartmentalized proteases are found in the cytoplasm of cells from all kingdoms of life,
as well as in mitochodria and chloroplasts. For example, E. coli contains five such
proteases: ClpXP, ClpAP, HslUV, Lon, and FtsH. Typically, the proteolytic active sites of
these enzymes reside within cylindrical or barrel-shaped structures, which are built from
rings containing six or seven subunits (Figure 1). For the double-ring ClpP 14 (part of
ClpXP) and HslV 12 (part of HslUV) enzymes, the "core peptidase" unit is formed from a
single type of polypeptide. For the 26S mammalian proteasome, the core 20S peptidase
component consists of multiple types of subunits and active sites (Murata et al. 2009).
CIpXP CIpAP 265 Proteasome
regulatory] ATPase (s)
core
peptidase
Figure 1. Averaged electron micrograph-derived images of three ATP-
dependent self-compartmentalized proteases, E. coli ClpXP, E. coli ClpAP,
and the yeast 26S proteasome (Grimaud et al. 1998; Wickner et al. 1999). The
regulatory AAA+ ATPases stack on one or both ends of the core peptidase to
form elongated barrel-like structures.
By themselves, ClpP14, HslV 14, and the 20S core of the proteasome cannot cleave protein
substrates and show only limited abilities to degrade small peptides. This restriction appears
to have a structural basis, as the proteolytic chambers of these enzymes are only accessible
through narrow axial channels, which have dimensions smaller than those of native proteins
(Sousa et al. 2001; Bajorek et al. 2004; Bewley et al. 2006). In complete self-
compartmentalized proteases (e.g., ClpXP, ClpAP, HslUV, or the 26S proteasome), the core
peptidase associates with one or two ATPases, which regulate access to the degradation
_ ____ _ _
chamber by recognizing specific substrates, unfolding them, and translocating the unfolded
substrate into the lumen of the peptidase (Figures 1 & 2).
protein /
substrate tag
ATP-powered
AAA+ unfoldase -
and translocase
compartmental _
peptidase -
substrate substrate I)
recognition unfolding, )
via peptide-tag translocation,
binding and degradation
Figure 2. Schematic of the ClpXP degradation cycle (Sauer et al. 2004), depicting
one ClpX hexamer (blue) bound to ClpPl 4 (purple). A native protein substrate
containing a ClpX recognition tag binds ClpX and is then mechanically unfolded
and translocated into the chamber of ClpP for proteolysis.
Degradation by self-compartmentalized proteases is processive and requires ATP hydrolysis
(Thompson et al. 1994b; Kim et al. 2000; Sauer et al. 2004; Martin et al. 2008b). Figure 2
shows a cartoon view of the ClpXP degradation reaction. Recognition is mediated by the
binding of a peptide tag at the terminus of a native substrate in the axial pore of the ClpX
hexamer. In a process that requires numerous cycles of ATP hydrolysis and appears to be
mediated by mechanical pulling, ClpX then denatures the native protein and translocates it
into ClpP for degradation (Ortega et al. 2000; Kenniston et al. 2003). Degradation is
processive because once protein unfolding occurs, there are no significant barriers that
would lead to release of the substrate. Moreover, within the ClpP chamber the concentration
of active sites is very high and thus most sites in the polypeptide that can be cleaved are
~I i ;
proteolyzed. The research described in this thesis focuses on the ClpXP system, with
specific attention to ClpP determinants that limit the degradation activity of the free
peptidase but allow it to cooperate effectively with ClpX in protein degradation.
CIpP AND ClpX
E. coli ClpXP is one of the best characterized compartmental proteases. Crystal structures
of ClpP14 and ClpX 6 (but not of the complex) are known (Wang et al. 1997; Glynn et al.
2009). Numerous peptide signals that target substrates to ClpX, either directly or via
adaptor proteins, have been identified (Gottesman 1996; Levchenko et al. 2000; Flynn et al.
2003). Studies of ClpXP degradation of model substrates have probed the energetic costs of
protein denaturation and translocation, and the processivity of degradation (Kenniston et al.
2003; Kenniston et al. 2004; Kenniston et al. 2005). Below, I summarize some of the
relevant information about these enzymes.
The crystal structure of E. coli ClpP14 was solved more than a decade ago (Wang et al.
1997). Face-to-face stacking of two homoheptameric rings results in a roughly spherical
degradation chamber with an internal diameter of -50 A (Figure 3). Each ClpP subunit
contains a Ser-His-Asp catalytic triad, which is the hallmark of serine proteases like
chymotrypsin. In the tetradecamer, 14 active sites occupy positions near the ring-ring
interface (Figure 3C). Modification of the ClpP active-site serine with
diisopropylfluorophosphate (DFP) inactivates the peptidase activity of ClpP and the protease
activity of ClpXP (Thompson et al. 1994b). Based on the structure, the only entrance to the
degradation chamber is through two narrow channels located at the axis of each heptameric
ring. These channels appear to have a diameter of -10 A, but this value could be lower if
unstructured portions of ClpP fill some of the space. Nevertheless, in the absence of
substantial conformational changes, the dimensions of the ClpP axial channel are far too
small to allow passage of native proteins. This simple structural argument was one of the
first indications that polypeptides enter the degradation lumen as elongated and unfolded
structures.
A
-95A
-eoA
C
catalytic
triads
Figure 3. Crystal structure of homotetradecameric E. coli ClpP (PDB 1YG6) with
each monomer shown in a different color. (A) Top view. (B) Side view. (C)
Cutaway of the side view shows the degradation lumen. The catalytic triads
(colored in red and indicated by red arrows) are near the ring-ring interface.
Mapping of the sites of cleavage in model substrates revealed that ClpP preferentially
cleaves after hydrophobic and aliphatic residues (Thompson et al. 1994a). As a
consequence of the high local concentration of active sites within the degradation chamber
and the broad cleavage specificity of ClpP, the products of ClpXP or ClpAP degradation are
typically peptides of 3-7 amino acids in length (Choi et al. 2005). Small peptides can enter
the degradation chamber of ClpP in the absence of a ClpX or ClpA partner, and cleavage
rates as high as -10,000 min' ClpP 14-1 have been reported (Thompson et al. 1994b;
Kenniston et al. 2003). By contrast, the maximal rates of protein degradation by ClpXP or
ClpAP are typically at least 1000-fold slower (Kim et al. 2000; Kenniston et al. 2003),
indicating that peptide-bond hydrolysis is not the rate limiting factor in degradation. In
some cases, the maximal rate of protein degradation is limited by the rate of protein
unfolding. In other cases, translocation appears to be the slow step in overall protein
degradation. Because ClpP degradation occurs in a enclosed chamber, cleavage products
must eventually exit the chamber to allow new substrates to enter. Two models have been
proposed for product egress: (i) cleaved peptides may exit via the same axial channels used
for substrate entry; or (ii) peptide exit may occur through small pores near the ring-ring
interface, which exist only transiently and are not observed in the wild-type crystal structure.
Although indirect evidence for the latter model has been presented (Gribun et al. 2005), this
issue remains unresolved.
ClpX is a member of the Clp/Hsp 100 subfamily of AAA+ (ATPases associated with various
cellular activities) ATPases (Schirmer et al. 1996; Neuwald et al. 1999). All members of
this subfamily assemble as ring homohexamers and function to unfold, disassemble, or
disaggregate proteins. These activities do not depend on association with a peptidase. For
example, Hsp104 and ClpB do not have peptidase partners, but function by themselves to
solubilize protein aggregates (Doyle et al. 2009). In addition, ClpX and ClpA can unfold
substrates or disassemble macromolecular complexes without assistance from ClpP
(Levchenko et al. 1995; Weber-Ban et al. 1999; Kim et al. 2000). The
unfolding/disassembly activities of ClpX, ClpA, and other Clp/Hspl00 enzymes require
ATP hydrolysis, which is thought to drive conformational changes that allow these enzymes
to mechanically unfold native substrates by attempting to pull these molecules through the
narrow axial channel of the ring hexamer. For both ClpX and ClpA, these axial pores have
been shown by mutagenesis and cross-linking experiments to serve as binding sites for the
peptide tags of specific substrates (Hinnerwisch et al. 2005; Martin et al. 2008a).
A B
Figure 4. Top (A) and side (B) views of the nucleotide-bound ClpX
homohexamer (PDB 3HWS), with each subunit depicted in a different color
(Glynn et al. 2009).
Crystal structures of ClpX hexamers in nucleotide-free and ADP-bound forms were
determined recently (Glynn et al. 2009). These structures have approximate two-fold
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symmetry, but the positions of the large and small AAA+ domains of individual subunits are
staggered up and down relative to the axis of the hexamer (Figure 4). As in other AAA+
ATPases, nucleotide binds at an interface formed by the large and small AAA+ domains of
one subunit and the large domain of a neighboring subunit (Hanson et al. 2005). The
rotation between domains in each subunit varies, however, and as a consequence only four
sites in the hexamer bind ADP or ATP. This asymmetry in nucleotide binding is consistent
with studies that show that the ClpX hexamer binds a maximum of four nucleotides in
solution (Hersch et al. 2005; Martin et al. 2005). Studies using covalently linked single-
chain hexamers of ClpX also support an asymmetric mechanism of ATP hydrolysis (Hersch
et al. 2005; Martin et al. 2005). In fact, ATP hydrolysis in a single ClpX subunit is
sufficient to support ClpXP-mediated degradation of native protein substrates. Two
structural features help explain this observation. First, the major subunit-subunit interface of
the hexamer consists of a rigid body formed by packing of a small AAA+ domain against
the large AAA+ domain of a neighboring subunit. Second, nucleotide binding alters the
rotation between the large and small domains of a single subunit. Thus, ATP binding or
hydrolysis in a single subunit could change the orientation between domains in this subunit,
and these conformational changes would be propagated around the entire hexameric ring via
the rigid-body interfaces. These changes, in turn, could drive up-and-down movements of
loops in the axial pore, which could be linked to substrate unfolding and/or translocation
(Glynn et al. 2009). Indeed, mutations in these pore loops cause defects in translocation and
unfolding (Martin et al. 2008a).
The axial channel of ClpX is rather narrow in the crystal structure, and some conformational
rearrangements would appear to be necessary to accommodate even a single translocating
polypeptide (Glynn et al. 2009). Nevertheless, biochemical studies using disulfide-
crosslinked substrates have shown that ClpXP can translocate as many as three polypeptide
chains simultaneously (Burton et al. 2001; Bolon et al. 2004). Although it is not yet known
how this is accomplished, the crystal structures suggest that unraveling of the domain-
domain linkers in the ClpX subunits that do not bind nucleotide might allow the pore to
open in an elastic fashion.
INTERACTIONS BETWEEN C1pX AND CIpP
ClpX rings are hexameric whereas ClpP rings are heptameric. Thus, the interactions that
stabilize the ClpXP complex and allow alignment of their pores to form a continuous
translocation channel must be inherently asymmetric. Because ATP-powered changes in
ClpX conformation can occur hundreds of times during degradation of a single protein
substrate (Kenniston et al. 2003), interactions between ClpX and ClpP must also be flexible
enough to avoid dissociation, which would lead to incomplete degradation.
Bioinformatic comparisons initially revealed the presence of surface loops containing a
hydrophobic-glycine-hydrophobic motif in all AAA+ family members that interacted with
ClpP (Kim et al. 2001; Martin et al. 2007). In E. coli ClpX, these loops are roughly 30
amino acids in length, contain an IGF tripeptide motif, and appear to be flexible, as most
residues are disordered in the crystal structure. Modeling shows that these "IGF" loops
would extend away from the base of the ClpX hexamer in a fashion that would allow at least
some of them to dock into hydrophobic depressions on the periphery of the top surface of a
ClpP ring (Figure 5). Point mutations in the IGF sequence of ClpX severely compromised
ClpP binding but did not affect ATP hydrolysis or ClpP-independent disassembly of
macromolecular complexes (Kim et al. 2001; Martin et al. 2007). Similarly, deletion of a
substantial portion of the IGF loop of ClpX eliminated detectable interactions with ClpP but
did not prevent ATP-dependent protein unfolding by the mutant enzyme (Joshi et al. 2004).
Using single-chain ClpX variants, Martin et al. (2007) showed that ClpX hexamers lacking a
single IGF loop bound ClpP -50-fold less well than wild-type ClpX but still functioned in
ClpXP degradation, whereas variants lacking two IGF loops failed to bind ClpP or support
degradation, irrespective of the geometric positions of the missing loops. Thus, a minimium
of five "peripheral" contacts between the IGF loops of a ClpX hexamer and ClpP are
required for formation of a functional proteolytic complex.
A B
ClpX
CIpX
SII;F loop
pore-2 loop
CIPP N-terminal loop
hydrophobic pocket
SCIpP
Figure 5. ClpX and ClpP interaction determinants (Martin et al. 2007). (A)
Schematic depicting peripheral interactions between the hydrophobic pocket of
ClpP (purple) and IGF loops of ClpX (green). Axial interactions involve N-
IN .. .. 11 11.1111 1 . . - ; ;
terminal loops of ClpP (red) and pore-2 loops of ClpX (blue). (B) Model of the
ClpXP complex showing both types of interactions.
Coaxial stacking of the ClpX and ClpP rings forms a continuous translocation channel
(Figure 5), and functionally important contacts between ClpX and ClpP are made at the sites
where the pores of the two rings contact each other. Several results suggest that the pore-2
loops of ClpX and the N-terminal loops of ClpP are responsible for at least some of these
"axial" contacts: (i) deletion of the ClpX pore-2 loops reduces ClpP affinity -15-fold but
does not prevent functional complex formation (Martin et al. 2007); (ii) deletion of N-
terminal residues of ClpP weakens or eliminates ClpX binding (Kang et al. 2004; Gribun et
al. 2005; Bewley et al. 2009); and (iii) cysteines introduced into the pore-2 loop of ClpX and
the N-terminal loop of ClpP can form a disulfide bond in a nucleotide-dependent fashion
(Martin et al. 2007).
Several results show that the nucleotide state of ClpX influences interactions with ClpP and
vice versa. First, ATP or ATPyS (a slowly hydrolyzed analog) is required for ClpX binding
to ClpP; no binding is observed without nucleotide or with ADP alone (Kim et al. 2000;
Joshi et al. 2004). Second, ClpP binding to ClpX reduces the basal rate of ATP hydrolysis
in a manner that depends on the presence of the pore-2 loops of the ATPase (Kim et al.
2000; Martin et al. 2007). Third, substrate-dependent changes in the rate of ATP hydrolysis
by ClpX alter its apparent affinity for ClpP (Joshi et al. 2004). Because of the staggered
arrangement of subunits in ClpX hexamers, only a subset of the pore-2 loops are close to the
bottom of the translocation channel and thus potentially in positions to contact ClpP (Glynn
et al. 2009). Moreover, the positions of these loops are expected to change through the
ATPase cycle, which could allow dynamic communication between the ATPase and
peptidase.
SUBSTRATE SELECTION BY C1pXP
Proteome-scale experiments in E. coli using a proteolytically inactive ClpP variant to trap
ClpXP substrates resulted in the identification of five classes of peptide sequences that can
target proteins for ClpXP degradation (Flynn et al. 2003). In general, these sequences were
short (3-10 residues), contained only a few residues that appeared critical for recognition,
and were located near the N- or C-terminus of the parent protein. Together with previous
studies of ClpX targeting (Levchenko et al. 1997; Gottesman et al. 1998; Gonciarz-Swiatek
et al. 1999), this work suggested that ClpX recognizes short, exposed peptide tags at the
extreme ends of a substrate.
The best-studied ClpXP recognition motif is the ssrA tag. In vivo, this 11-residue sequence
(AANDENYALAA in E. coli) is appended to the C-terminus of nascent polypeptides when
protein synthesis on the ribosome stalls (Keiler et al. 1996). Tagging occurs co-
translationally in a process mediated by alanine-charged tmRNA, which functions first as a
tRNA to add the alanine to the nascent chain and then as an mRNA to direct synthesis of the
ANDENYALAA portion of the tag. These events allow normal termination of translation,
ribosome recycling, and release of the nascent polypeptide as an ssrA-tagged molecule.
Degradation of ssrA-tagged proteins in the cytoplasm of E. coli is carried out largely by
ClpXP (Farrell et al. 2005; Lies et al. 2008), preventing deleterious effects due to the
accumulation of incomplete and potential harmful polypeptides. From a biochemical
perspective, the ssrA tag has been very useful because appending it to the C-terminus of
nearly any protein by cloning makes the tagged protein a substrate for ClpXP degradation
(Gottesman et al. 1998; Kim et al. 2000; Kenniston et al. 2003). Mutagenesis experiments
have shown that the C-terminal LAA residues of the ssrA tag are most important for
recognition by ClpX and degradation by ClpXP (Flynn et al. 2001). Indeed, a number of
natural ClpXP substrates have similar genetically encoded recognition tags. For example, E.
coli RecN (a protein induced as part of the SOS repsonse to DNA damage) is synthesized
with a C-terminal LAA sequence, which targets it for constitutive degradation by ClpXP
(Neher et al. 2006). Thus, RecN can only be maintained at modest steady-state intracellular
levels if it is transcribed and translated very efficiently.
Sometimes, more than one peptide tag is required for efficient ClpXP degradation. For
example, the N-terminal residues of XO - a tetrameric protein needed for replication
initiation by phage X - is targeted for ClpXP degradation by its N-terminal residues
(Gonciarz-Swiatek et al. 1999). Appending these residues from XO to a monomeric
substrate results in relatively inefficient degradation because KM is high, whereas appending
them to a dimeric substrate reduces KM and increases the second-order rate constants for
degradation (Farrell et al. 2007). In this instance, multivalent contacts between the two XO
tags in the dimer and sites in the ClpX hexamer probably result in stronger multimer
binding. Similarly, ClpX binds tetrameric forms of MuA transposase more tightly than the
monomer (Abdelhakim et al. 2008). MuA tetramerizes during the process of DNA
transposition, allowing specific targeting of the multimeric transpososome for disassembly
by ClpX. Indeed, if the hyper-stable complex of MuA with recombined DNA cannot be
dissociated, then subsequent replication of phage Mu is blocked. In both the kO and MuA
examples, multivalent recognition provides a way to target ClpX to substrate multimers with
higher efficiency than to individual subunits. In principle, degradation tags for ClpXP could
also be masked in an oligomer and only become accessible upon dissociation, allowing
individual subunits but not complexes to be targeted for degradation (Baker et al. 2006).
Multivalent substrate delivery is generally more efficient because binding of the first tag
occurs in a bimolecular reaction, whereas the second tag binds in a unimolecular reaction
with a lower entropic cost. Adaptors use this tactic to enhance degradation of heterologous
proteins by binding to both the substrate and to the protease. For example, SspB is a dimeric
adaptor protein, initially discovered as a factor that enhanced ClpXP degradation of ssrA-
tagged substrates (Levchenko et al. 2000). One part of each SspB subunit binds to the
AANDENY portion of the ssrA tag (Levchenko et al. 2000; Flynn et al. 2001; Levchenko et
al. 2003; Song et al. 2003). At the same time, a flexible C-terminal tail in each SspB subunit
binds to ClpX (Figure 6). Formation of this ternary complex increases the local
concentration of the substrate relative to the protease, decreasing KM and increasing the
ClpXP degradation rate at low concentrations of ssrA-tagged substrates.
Adaptors can also reorganize the landscape of substrates to be degraded. For example, some
ClpXP substrates in the cell are degraded at enhanced rates in the presence of SspB, whereas
others are degraded more slowly (Flynn et al. 2004). One model to explain this finding is
that the tails of SspB compete with certain substrates for binding to ClpX. Biochemical
experiments using purified proteins in vitro show that ClpAP degrades ssrA-tagged
substrates at rates similar to or faster than ClpXP (Gottesman et al. 1998; Weber-Ban et al.
1999; Kim et al. 2000). In an E. coli cell, however, ClpAP plays only a minor role in
degrading ssrA-tagged substrates (Farrell et al. 2005; Lies et al. 2008). Some of this
difference appears to be mediated by SspB, as binding of this adaptor to the ssrA tag of
model substrates enhances degradation by ClpXP but slows degradation by ClpAP (Flynn et
al. 2001).
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Figure 6. The SspBosubstrate complex binds ClpXP to form a ternary
complex that leads to efficient protein degradation (McGinness et al. 2006).
ClpP MATURATION AND REGULATION OF INTRINSIC ACTIVITY
How is the proteolytic activity of ClpP repressed in the free enzyme and activated by ClpX
binding? Like many serine proteases (Stroud et al. 1977), E. coli ClpP is initially
synthesized as a proenzyme with a 14-residue N-terminal extension (Maurizi et al. 1990).
Assembly of the complete ClpP tetradecamer appears to be required before autoproteolytic
.............................
removal of the propeptide can occur. It is not clear how the propeptide limits ClpP activity
or what specific signals trigger its cleavage, but this requirement for maturation probably
prevents ClpP from degrading substrates prior to formation of its compartmental barrel-
shaped structure which can limit substrate access to the active sites.
A somewhat different strategy appears to be used for controlling the activity of human
mitochondrial ClpP. In this case, the free enzyme forms a single heptameric ring with
extremely low peptidase activity and no protease activity, and the presence of ClpX is
required for assembly of the active double-ring structure (Kang et al. 2005). These
observations suggest that the Ser-His-Asp catalytic triads in an isolated heptameric ring of
human ClpP are present in a non-functional conformation and that allosteric changes in
structure, stabilized by ClpX binding, are required for activation. It is possible that single
rings of E. coli ClpP are also inactive, and thus that assembly of the 14-mer is a prerequisite
for activity.
Studies with other compartmental peptidases and AAA+ proteases have documented two
distinct mechanisms by which binding of the AAA+ ATPase can control the activity of the
peptidase. One of these mechanisms, involving active site rearrangement, is used by the
AAA+ HslUV protease. HslU is a hexameric AAA+ ATPase, which shares significant
sequence and structural homology with ClpX; HslV is its partner compartmental peptidase
(Kessel et al. 1996). Although HslV forms an enclosed proteolytic chamber like ClpP, these
enzymes differ in almost all other ways. For example, HslV does not have a Ser-His-Asp
catalytic triad and instead uses its N-terminal threonine as the attacking nucleophile in
peptide-bond cleavage. Moreover, the three-dimensional structures of HslV and ClpP
subunits are completely different, and the fully assembled HslV enzyme is a 12-mer
consisting of two hexameric rings. Importantly, the isolated HslV 12 enzyme has no
detectable peptidase activity, and its active-site threonines do not react with peptide vinyl-
sulfone inhibitors (Yoo et al. 1996; Bogyo et al. 1997). In HslUV complexes, by contrast,
robust peptidase activity in observed and the active-site threonines react readily with vinyl-
sulfone inhibitors. These results suggested that the active sites in free HslV 12 are either
completely inaccessible or are not in catalytically functional conformations. The latter
model is strongly supported by comparisons of the crystal structures of HslV 12, free or in
complex with two HslU 6 molecules, which show that the active sites only adopt a functional
conformation in the HslUV complex (Sousa et al. 2002). Furthermore, in complexes of
HslV 12 containing just a single hexamer of HslU, only the active-site threonines in the HslV
ring in direct contact with HslU were reactive with vinyl-sulfone inhibitors, demonstrating
that each HslV ring is activated independently rather than cooperatively by HslU binding
(Kwon et al. 2003).
A second mechanism that has been documented for control of compartmental peptidase
activity is gate opening. The best example involves the 20S proteasome core particle, which
is composed of four stacked heptameric rings with two types of subunits in an 77 7a7
arrangement (Murata et al. 2009). The 20S proteasome can degrade depeptide substrates
efficiently but has almost no activity against larger peptides (Groll et al. 2003). In the free
20S enzyme, flexible N-terminal sequences in each flanking c7 ring protrude into the axial
entry channels, effectively blocking entry of small peptides 3-4 amino acids long and
deletion of these N-terminal a sequences allows faster degradation (Groll et al. 2000).
Crystal and cryo-EM structures of the core particle in complex with 11S non-AAA+
activators reveal rearrangements that result in pore or gate opening (Rabl et al. 2008).
Together, these results support a model in which the N-termini of the a subunits physically
gate access of polypeptides to the lumen of the degradation chamber.
RESEARCH APPROACH
Since the publication of the first ClpP crystal structure (Wang et al., 1997), workers in the
field have generally assumed that a gating mechanism is used to control substrate access to
the degradation chamber in the free enzyme. Somewhat surprisingly, however, many
aspects of this model had not been investigated, and an allosteric model had not been ruled
out. Indeed, recent studies appeared to provide some evidence for allosteric activation, as
deleting ClpP residues that form part of the axial channel resulted in defects in hydrolysis of
the acyl-enzyme intermediate (Jennings et al. 2008). It is also possible that the ClpP
propeptide inhibits activity in an allosteric fashion, and an allosteric model provides one
explanation for the observation that DFP-modified ClpP binds ClpX with higher affinity
than unmodified ClpP (Joshi et al. 2004). As a result, I became interested in understanding
how ClpP activity is regulated in the absence and presence of ClpX.
I approached this question using genetic and biochemical experiments. In Chapter 2, I
present experiments involving peptide degradation and active-site modification that support
an important role for the N-terminal residues of ClpP in gating substrate entry. These
studies also showed that sequence determinants in a-helix A, which links the pore residues
of ClpP to the peripheral binding clefts, play critical roles in binding ClpX. Interestingly,
ClpP mutations that severely impaired ClpX binding had relatively small effects on ClpA
interactions, suggesting that these AAA+ ATPases must interact with ClpP in somewhat
different ways. Finally, I found that sequences that form the axial channel of ClpP play
roles in determining the specificity of polypeptide entry into the peptidase chamber during
ClpXP degradation.
In Chapter 3, I describe a genetic selection for dominant-negative ClpP mutations that
impair wild-type ClpXP function. Using this selection, I identified point mutations in
multiple regions of the three-dimensional structure that prevent or diminish function. The
majority of mutations mapped to the N-terminal channel residues and a-helix A, the
peripheral IGF-binding clefts, the ring-ring interface of ClpP, and active sites. I
characterized several of these mutants, and discuss potential mechanisms to explain the
phenotypes observed. In the first appendix to Chapter 3, I describe a selection for ClpX
mutations that restore the ability to interact functionally with a ClpP mutant that fails to bind
wild-type ClpX and preliminary results of this selection. The second appendix describes
characterization of two mutations in the peripheral IGF-binding clefts.
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CHAPTER TWO:
Control of substrate gating and translocation into ClpP by channel
residues and ClpX binding
ABSTRACT
ClpP is a self-compartmentalized protease, which has very limited degradation activity
unless it associates with ClpX or ClpA to form the AAA+ ClpXP or ClpAP proteases. Here,
we show that ClpX binding stimulates ClpP cleavage of peptides larger than a few amino
acids and enhances ClpP active-site modification. Stimulation requires ATP binding but not
hydrolysis by ClpX and increases with molecular weight in a manner consistent with
diffusion of peptides or inhibitors into the ClpP proteolytic chamber. Amino-acid
substitutions in the axial channel or helix A of ClpP interfere with proper substrate gating in
the free enzyme and weaken ClpX binding. For example, the I19A mutation in helix A
results in a ClpP enzyme that degrades unfolded proteins and eliminates ClpX binding.
Channel mutations in ClpP also prevent ClpXP translocation of certain amino-acid
sequences, suggesting that the channel plays an active role in translocation specificity. These
results support a model in which the channel residues of free ClpP exclude efficient entry of
all but the smallest peptides into the degradation chamber. ClpX binding relieves these
inhibitory interactions, presumably by opening the channel pore, and sets up additional
interactions required for functional communication with ClpP and robust translocation.
INTRODUCTION
Intracellular protein degradation is an important facet of proteome maintenance (Lopez-Otin
et al. 2002; Weichart et al. 2003; Haynes et al. 2007; Hengge et al. 2009; Powers et al.
2009), and misregulation of proteolysis can lead to severe cellular defects (Turk 2006). One
strategy that helps to ensure that only the proper intracellular proteins are degraded is to
sequester proteolytic enzymes within organelles, such as lysosomes or vacuoles (Ivanova et
al. 2008; Hengge et al. 2009). In such cases, only specific proteins that are transported into
the organelle and subsequently recognized by the protease will be degraded. A different but
related strategy is to assemble cytoplasmic proteases into self-compartmentalized structures
in which the proteolytic active sites are sequestered within the lumen of a barrel-shaped
chamber, which is only accessible through narrow axial channels or pores (Sauer et al. 2004;
Striebel et al. 2009). In this case, proteins that are substrates of the protease are typically
recognized by an associated AAA+ ATPase, unfolded if necessary, and then translocated
into the proteolytic chamber (Sauer et al. 2004).
ClpP is a self-compartmentalized protease, formed by the stacking of two heptameric rings
(Maurizi et al. 1990; Wang et al. 1997). It associates with AAA+ hexamers of either ClpX or
ClpA to form the ATP-dependent proteases, ClpXP or ClpAP (Yu et al. 2007; Striebel et al.
2009). Similarly, the HslUV protease consists of a compartmentalized protease (HslV) and a
AAA+ ATPase (HslU), whereas the 26S proteasome is composed of the compartmentalized
20S proteasome core and the 19S regulatory complex (Pickart et al. 2004). By themselves,
the free forms of ClpP, HslV, and the 20S proteasome core do not degrade native or
denatured proteins (Thompson et al. 1994a; Thompson et al. 1994b; Yu et al. 2007). Thus,
mechanisms must exist to limit the destructive potential of these isolated enzymes. The
importance of proper regulation of proteolytic activity is highlighted by the action of
acyldepsipeptide antibiotics, which kill bacteria by binding ClpP, preventing association
with ClpX or ClpA, and endowing ClpP with the ability to degrade unfolded polypeptides,
including nascent chains (Brotz-Oesterhelt et al. 2005; Kirstein et al. 2009).
Two distinct mechanisms can limit the activity of self-compartmentalized proteases in the
absence of their AAA+ partners. One mechanism involves active-site rearrangment. For
example, when HslU is absent, the active-site residues of HslV assume an inactive
conformation and fail to cleave even small peptide substrates or to react with peptide vinyl-
sulfone inhibitors (Yoo et al. 1996; Bogyo et al. 1997; Sousa et al. 2000; Sousa et al. 2002).
In this instance, binding of an HslU ring to an HslV ring is required to remodel the peptidase
active sites (Sousa et al. 2002; Kwon et al. 2003). The second mechanism involves gating or
controlling substrate access to the proteolytic chamber of the compartmental peptidase. For
example, crystal structures show that the active sites in the chamber of the isolated 20S
proteasome are arranged in a functional conformation but substrate access to these sites is
severely limited by residues which sterically block the entrance pore (Groll et al. 2000; Groll
et al. 2003; Rabl et al. 2008). This blockade is relieved by structural rearrangements that
accompany binding of the 20S core to the 19S regulatory complex or to non-ATPase
regulators such as PA26, allowing substrate access and degradation (Smith et al. 2005;
Smith et al. 2007).
We are interested in the mechanism(s) that repress the proteolytic activity of the isolated
ClpP enzyme and that allow activation by ClpX. E. coli ClpP is initially expressed as a
proenzyme, which is autoproteolytically processed to remove an N-terminal propeptide
(Maurizi et al. 1990). Crystallographic studies of the mature ClpP tetradecamer reveal
canonical Ser-His-Asp catalytic triads and a properly formed oxyanion hole (Wang et al.
1997; Kang et al. 2004; Gribun et al. 2005; Bewley et al. 2006; Szyk et al. 2006; Ingvarsson
et al. 2007; Kim et al. 2008), which appear to be functional as free ClpP can degrade small
peptides and reacts with diisopropylfluorophosphate, an active-site inhibitor (Thompson et
al. 1994a; Thompson et al. 1994b). The axial channel of free ClpP is formed by N-terminal
stem-loop structures, with the stems forming the rim of the pore and the loops forming the
channel (Wang et al. 1997; Kang et al. 2004; Gribun et al. 2005; Bewley et al. 2006; Szyk et
al. 2006; Ingvarsson et al. 2007; Kim et al. 2008). This channel is too narrow to admit native
proteins and even large peptides are degraded very slowly (Grimaud et al. 1998; Maurizi et
al. 1998). However, deletion of segments of the pore and channel allow degradation of
unfolded proteins, which are not degraded by wild-type ClpP alone (Bewley et al. 2009).
Moreover, ClpP degradation of large peptides can be stimulated substantially by ClpA
binding (Thompson et al. 1994b). All of these results are consistent with regulation of ClpP
proteolytic activity by a simple gating mechanism. However, recent studies suggest that
allosteric regulation of the active-site conformation of ClpP by ClpX or ClpA binding may
also be required under some circumstances to allow hydrolysis of the acyl intermediate in
peptide-bond cleavage (Jennings et al. 2008).
Electron microscopy (EM) shows that hexameric rings of ClpX or CIpA stack coaxially with
the heptameric rings of ClpP, aligning the central translocation channel of the AAA+
ATPase with the ClpP pore (Grimaud et al. 1998; Ortega et al. 2000). There are no crystal
structures of ClpXP or ClpAP, however, and the resolution of the EM structures are
insufficient to observe atomic details. It is known that formation of these active proteolytic
complexes requires ATP or ATPyS, affects the rate of ATP hydrolysis, and requires
conserved IGF/IGL motifs located in loops on the AAA+ ring that appear to dock into
hydrophobic clefts on the periphery of the ClpP ring (Kessel et al. 1995; Grimaud et al.
1998; Kim et al. 2001; Singh et al. 2001; Joshi et al. 2004; Martin et al. 2007; Bewley et al.
2009). Amino acids that form the axial pore and channel of ClpP also appear to play roles in
recognition of the AAA+ rings of ClpX and ClpA (Kang et al. 2004; Gribun et al. 2005;
Bewley et al. 2006; Martin et al. 2008a; Bewley et al. 2009).
In this paper, we test predictions of the pore-gating model for ClpP and investigate the role
of ClpX in controlling gating. We find that ClpX binding stimulates ClpP cleavage of
peptide substrates larger than a few amino acids in a reaction that does not require ATP
hydrolysis. Moreover, this stimulatory effect increases as a function of peptide molecular
weight, as expected if ClpX binding increases the rate at which peptides diffuse into ClpP.
ClpX binding also stimulates active-site modification of ClpP by fluorophosphates, but only
to a level expected from faster diffusion of the inhibitor into the ClpP chamber. The ability
of wild-type ClpP to exclude large peptides depends on interactions mediated by the channel
region of the pore and by conserved residues in a-helix A. Indeed, a single mutation in helix
A results in a ClpP enzyme that degrades unfolded proteins in the absence of a AAA+
partner. Mutations in the ClpP channel and helix A also weaken ClpX binding and affect
communication during the degradation of protein substrates. Importantly, we find that ClpP
channel mutations can prevent ClpXP translocation of certain amino-acid sequences,
suggesting that the wild-type ClpP channel plays an active role in the specificity of the
translocation reaction. Overall, our results support a model in which the channel residues in
free ClpP prevent efficient entry of all but the smallest peptides into the degradation
chamber. ClpX binding relieves these inhibitory interactions, presumably by opening the
channel, and sets up additional interactions with ClpP that are required for functional
communication and robust translocation.
RESULTS
Active-site reactivity of C1pP
In an initial set of experiments, we used the rhodamine-labeled fluorophosphate inhibitor
developed by Cravatt and colleagues (Rh-FP; MR 845 Da) (Liu et al. 1999) to probe the
reactivity of the active-site serines of E. coli ClpP, both alone and in complex with E. coli
ClpX. For these experiments, the fluorescent inhibitor was incubated with ClpP, with ClpP
plus ClpX*ATPyS, or with ClpP plus ClpX*ADP for different times before quenching the
reaction. Samples were then analyzed by SDS PAGE and fluorimetry. In the ClpX*ATPyS
experiment, the rate of active-site modification by Rh-FP was ~3-fold faster than for ClpP
alone (Figure 1A). The rate of modification with ClpX*ADP, which does not bind ClpP, was
the same as that measured for ClpP alone. Thus, ClpX binding modestly enhances the rate of
active-site modification of ClpP. Importantly, this result is very different from that observed
for HslV, where no active-site modification was observed in the absence of HslU*ATP
(Bogyo et al. 1997), and is consistent with crystallographic results that reveal a well-formed
catalytic triad and oxyanion hole in the structure of ClpP alone (Wang et al. 1997). The
modest ClpX stimulation of ClpP active-site reactivity probably occurs because ClpX
binding enhances the rate at which the inhibitor diffuses into the ClpP chamber.
ClpX stimulates ClpP peptide cleavage in a size-dependent fashion
Early biochemical studies demonstrated that ClpA*ATPyS did not stimulate ClpP cleavage
of very small peptides but did stimulate cleavage of longer peptides (Thompson et al.
1994b). To test this possibility for ClpX, we assayed the dependence of ClpP cleavage of a
dipeptide substrate (succinyl-LY-AMC; MR 552 Da), a decapeptide substrate (MR 1219 Da),
and a 20-residue substrate (MR 2404 Da). The 10- and 20-residue substrates were flanked by
a fluorophore (2-aminobenzoic acid) and quencher (3-nitrotyrosine) to allow cleavage to be
detected by increased fluorescence. The rates of dipeptide cleavage by ClpP alone or in the
presence of ClpX*ATPyS were within error (Figure IB). By contrast, ClpXP*ATPyS cleaved
the decapeptide ~9-fold faster and the 20-residue substrate ~40-fold faster than ClpP by
itself (Figure IB).
ClpX can use ATPyS hydrolysis, which occurs 10- to 20-fold more slowly than ATP
hydrolysis, to power protein unfolding, translocation, and degradation (Burton et al. 2003;
Martin et al. 2008b). To test if nucleotide hydrolysis by ClpX was required for enhanced
ClpP cleavage of the decapeptide substrate, we also determined rates in the presence of
ClpX*ATP and ClpXE2 15Q*ATPyS. The ClpXE28 5Q mutant harbors a substitution for a highly
conserved glutamate in the Walker B motif and is defective in ATP hydrolysis (Hersch et al.
2005). In both cases, decapeptide cleavage occurred at similar rates to those observed with
ClpXoATPyS (Figure 1C). No stimulation of cleavage was observed with ClpX*ADP
(Figure 1C). We conclude that nucleotide hydrolysis is not essential for ClpX stimulation of
peptide degradation by ClpP.
Figure ID shows that activity stimulation by ClpX increases as a function of the molecular
weight of the compound that needs to enter ClpP. These findings, in conjunction with
previous results, support a model in which ClpX binding to ClpP facilitates faster diffusion
of Rh-FP, the decapeptide substrate, and the 20-residue substrate into the proteolytic
chamber of ClpP. Because the dipeptide substrate seems to enter the chambers of ClpP and
ClpXP at comparable rates, it appears that the pore in isolated ClpP only restricts entry of
compounds with a higher molecular weight or larger radius of gyration. It might be argued
that changes in the diffusion rate of the dipeptide are masked by ClpX stimulation of ClpP
active-site reactivity. If this were true, however, then the dipeptide would have to diffuse
more slowly into ClpXP than into ClpP, making it difficult to explain the results with the 10-
and 20-residue peptides.
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Figure 1. Changes in ClpP activity in response to ClpX binding. (A) Rate of ClpP reactivity
with the active-site inhibitor rhodamine-FP. The inset gel shows the fluorescence of
rhodamine-FP modified ClpP as a function of time after addition of the inhibitor with or
without ClpX and ATPyS/ADP. The graph represents quantification of band intensities from
the gel. (B) Rates of ClpP cleavage for a dipeptide (succinyl-LY-AMC), a decapeptide (Abz-
KASPVSLGyN0 2D), and a 20-residue peptide (Abz-ASSHATRQLSGLKLHSNLyNO2H)
were determined in the presence and absence of ClpX*ATPyS and were normalized to the
rate observed for ClpP alone. (C) Rates of ClpP cleavage of the decapeptide were determined
in the presence of wild-type ClpX or the ATPase defective CLpXE1 5Q mutant and different
nucleotides. (D) ClpX*ATPyS stimulation of the rate of ClpP peptide cleavage or active-site
modification is plotted as a function of the molecular weight of the peptide substrate or the
active-site inhibitor. The solid line is a fit to a polynomial function. In panels B-D, the data
are averages of triplicate experiments and the error bars represent one standard deviation
from the mean.
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Substitution mutations in the ClpP channel activate peptide cleavage
Truncated variants of ClpP, lacking 7-14 N-terminal residues of the mature enzyme, show
faster degradation of large peptides (Jennings et al. 2008; Bewley et al. 2009). We sought to
determine whether substitutions for residues 8-15, which form the channel loop of the pore
(Figure 2A), could also alter ClpP's ability to discriminate against longer peptides. Indeed,
when we replaced residues 8-15 with eight glycines, this mutant (GGGGGGGG 15) cleaved
the decapeptide at a rate ~8-fold faster than that observed with wild-type ClpP (Figure 2B)
but cleaved the dipeptide at a comparable rate (Figure 2C). Mutations in the N-terminal loop
can alter ClpP processing (Bewley et al. 2006). However, the GGGGGGGG'15 mutant was
properly processed by the criteria that it had the same mobility as wild-type ClpP during
SDS PAGE (data not shown) and the expected molecular weight in MALDI-TOF mass
spectrometry experiments (calculated 22141 Da; observed 22166Da).
Residues 8-15 of wild-type E. coli ClpP include four highly conserved charged residues
(EQTSRGER 15). To probe the importance of these charged channel residues, we constructed
and purified mutants in which these charges were reversed (RQTSEGRE 5), were replaced
by glycines (GQTSGGGG 15), or were replaced by alanines (AQTSAGAA 5 ). Each of these
mutants was properly processed, behaved like wild-type ClpP during purification, and
exhibited similar rates of degradation of the succinyl-LY-AMC dipeptide (Figure 2C) but
cleaved the decapeptide ~10-fold faster than wild type (Figure 2B). These results suggest
that proper regulation of access to the proteolytic chamber of ClpP requires interactions
mediated by specific charged residues in the wild-type channel.
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Figure 2. Activity of ClpP variants with mutations in the N-terminal channel loops. (A) Side
view of the crystal structure of ClpP (pdb code 1YG6) showing the location of the N-terminal
channel loops (residues 8-15) in blue and the Ser-His-Asp catalytic triad in red. (B) Rates of
decapeptide (15 pM) cleavage by wild-type ClpP and the channel variants (0.3 YM). The
channel-loop sequence for each mutant is shown. Values are averages (n=3) ± 1 SD. (C) Rates
of succinyl-LY-AMC (50 pM) cleavage by ClpP and the channel variants (0.1 M). Values are
averages (n=3) ± 1 SD. (D) Rates of ClpXP degradation of GFP-ssrA (5 /M). Reactions
contained ClpX (0.1 pM hexamer) and different quantities of wild-type ClpP or the channel
variants. Solid lines are fits to a hyperbolic function. (E) Non-additive effects of ClpX (6.8 pM
hexamer plus 1 mM ATPyS) and the AQTSAGAA 15 channel mutations on ClpP (0.3 pM
tetradecamer) cleavage of the decapeptide (15 pM). Values are averages (n=3) ± 1 SD.
B
8g.
jo.
C
90.
*S1
0.3
~--------------------------------------- ;I
Channel residues influence ClpX binding and ClpXP degradation
To assess the effects of our channel mutations on ClpX interactions, we titrated increasing
quantities of the mutant variants or wild-type ClpP against a fixed concentration of ClpX
and assayed degradation of GFP-ssrA. The ssrA tag targets substrates to the axial pore of
ClpX, and unfolding and subsequent degradation of GFP-ssrA require ATP hydrolysis (Kim
et al. 2000; Siddiqui et al. 2004; Martin et al. 2008b). As assayed by loss of native
fluorescence, GFP-ssrA degradation was observed in the experiments using wild-type ClpP
or AQTSAGAA 15 ClpP but was not detected using the RQTSEGRE 15, GQTSGGGG 15, and
GGGGGGGG 15 ClpP variants at the highest concentrations tested (Figure 2D). Moreover,
substantially higher concentrations of the AQTSAGAA 15 mutant than of wild-type ClpP
were required for half-maximal stimulation of proteolysis, and the GFP-ssrA degradation
rate at saturation was approximately 2-fold slower for the AQTSAGAA 15 mutant than for
wild-type ClpP (Figure 2D). We conclude that residues in the ClpP channel play important
roles both in binding ClpX and in determining the maximal rate of degradation of native
protein substrates.
ClpP-channel residues facilitate translocation of specific substrate sequences
Peptides with a C-terminal ssrA tag, a preceding guest region of variable sequence, and an
N-terminal module with a cleavage site flanked by a fluorophore and quencher provide a
convenient assay for ATP-dependent degradation that requires ClpXP engagement and
translocation but not protein unfolding (Barkow et al. 2009). It seemed possible that
degradation of an ssrA-tagged peptide might be more permissive than degradation of GFP-
ssrA. Hence, we titrated increasing ClpX against a fixed concentration of the ClpP channel
variants or the wild-type enzyme and assayed degradation of a 33-residue peptide containing
a YGYGYGYGYG guest sequence ([YG] 5-ssrA). To restrict degradation of this substrate
via passive diffusion into the ClpP proteolytic chamber, we added the SspB protein, which
binds part of the ssrA tag and restricts the bound peptide from entering ClpP unless ClpX is
present and can interact functionally with ClpP (Flynn et al. 2001; Levchenko et al. 2003;
Song et al. 2003; Barkow et al. 2009). At the highest ClpX concentrations tested (8 pM),
RQTSEGRE15 and GQTSGGGG 15 ClpP showed no increase in degradation of the [YG]5-
ssrA peptide (Figure 3A), mirroring the results obtained using GFP-ssrA as the substrate. As
expected, degradation of this peptide by ClpP or the AQTSAGAA 15 mutant increased as a
function of ClpX concentration and then saturated (Figure 3A). Compared to wild-type
ClpP, half-maximal stimulation of degradation of the [YG] 5-ssrA substrate by
AQTSAGAA1 5 ClpP required an approximate ~10-fold higher concentration of ClpX and
the degradation rate was ~6-fold slower when ClpX was saturating (Figure 3A).
Intriguingly, AQTSAGAA 5 ClpXP degraded native GFP-ssrA at ~50% of the wild-type rate
but only degraded the unfolded [YG]5-ssrA peptide at ~20% of the corresponding wild-type
velocity (Figures 2D & 3A). We also tested degradation of additional ssrA-tagged peptides
with different guest sequences for degradation by AQTSAGAA 15 ClpXP as well as wild-
type ClpXP (Figure 3B). Surprisingly, AQTSAGAA'15 ClpXP showed almost no degradation
of peptides with 10 glutamic acids, 10 lysines, or four glycines in the guest region.
Somewhat higher rates were observed for peptides with guest regions containing 10
glutamines, 10 arginines, or six alanines (Figure 3B). Peptides with guest regions containing
proline or repeats of tyrosine-glycine or phenyalanine-glycine were degraded at the highest
rates by AQTSAGAA 15 ClpXP. In all cases, wild-type ClpXP degraded the same peptides
substantially faster (Figure 3B). Thus, mutating the charged residues in the wild-type ClpP
channel to alanines seems to restrict translocation of charged, polar, and small amino acids
more than it affects translocation of more hydrophobic side chains. Therefore, the chemical
identity of the amino acids that form the wild-type channel appear to play roles in
determining translocation specificity.
Non-additivity of ClpP channel mutations and ClpX binding
ClpX binding stimulated degradation of the decapeptide substrate by wild-type ClpP roughly
10-fold (Figure IB) and the AQTSAGAA 15 channel mutations resulted in a similar increase
in decapeptide cleavage by the free mutant enzyme compared to wild-type ClpP (Figure
2B). However, when we titrated increasing ClpX against a constant quantity of
AQTSAGAA 15 ClpP and assayed decapeptide degradation in the presence of ATPyS, no
increase in cleavage was observed (Figure 2E), although based on experiments in the
previous section, ClpX binds to AQTSAGAA 5 ClpP (Figure 2D). This observed lack of
additivity in decapeptide cleavage could be explained if the channel mutations and ClpX
binding affect ClpP gating by similar mechanisms.
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Figure 3. Degradation of peptides containing an N-terminal Abz-FAPHMALVPYNO 2, a
guest region, and a C-terminal KKAANDENYALAA (ssrA tag underlined). (A) Rates of
ClpXP degradation of a 33 residue ssrA-tagged peptide (8 pM) with a [YG], guest region.
Each reaction contained ClpP14 or mutant variants (0.15 /M), SspB (8 pM), and different
quantities of wild-type ClpX. Solid lines are fits to the Hill equation. (B) Rates of
ClpX*ClpP or ClpX*ClpP-AQTSAGAA 15 of ssrA-tagged peptide substrates with different
guest regions. The rates shown were corrected by subtracting background cleavage by ClpP
or CIpP-AQTSAGAA' 5 only. Values are an average of two determinations. Guest regions:
[E10], 10 glutamic acids; [Rio], 10 arginines; [Ko0], 10 lysines; [Q 1o], 10 glutamines, [A6], six
alanines; [G4], four glycines; [P5], five prolines; [FG]5, five phenylalanine-glycine repeats;
and [YGs], five tyrosine-glycine repeats. All reactions contained 8 /M peptide, 8 /M SspB,
0.15 pM ClpX 6, and 4/pM ClpP 14.
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Helix-A residues play roles in substrate gating
In a screen for dominant-negative ClpP mutations that prevent or reduce wild-type ClpXP
activity, we isolated I19T and S21Y mutations in helix A (see Chapter 3). This helix, which
consists of residues 19-25, is immediately proximal to the N-terminal channel loops and
pore in the ClpP structure (Figure 4A), and Ile' 9 and Leu24 in helix A form a hydrophobic
cluster with Phe49 and pore-stem residues Pro4 and Val6 (Figure 4B). To investigate the role
of helix A in ClpP activity, we constructed alanine-substitution mutations at each helix-A
residue, purified the mutant enzymes, and assayed peptidase activity. All of these mutants
showed wild-type levels of succinyl-LY-AMC cleavage (data not shown), but decapeptide
rates differed substantially (Figure 4C). Relative to wild-type ClpP, for example, the R22A
and K25A mutations caused small increases (~1.5 fold) in decapeptide cleavage, the Y20A,
S21A, and L23A mutations caused modest increases (~5 fold), and the I19A and L24A
mutations caused large increases (~20 fold). We also constructed and purified mutants with
more conservative leucine and valine substitutions for Ile' 9. Decapeptide cleavage was
increased ~6 fold by the I19L mutation and ~16 fold by the 119V mutation (Figure 4D).
Thus, even subtle changes in the stereochemistry of the side chain of residue 19 alter ClpP
gating.
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Figure 4. Helix A plays a role in regulating peptide degradation. (A) Structure of a
ClpP subunit (pdb code 1YG6) showing residues 8-15 of the N-terminal channel
loop, (blue), helix A (green), and the catalytic triad (red). (B) Pro4, Val6, and Ile19
from one subunit pack in a hydrophobic cluster with residues Leu24 and Phe49
from a neighboring ClpP subunit. (C) Rates of decapeptide (15 yM) degradation
for wild-type ClpP 14 and helix-A mutants (0.3 pM). (D) Decapeptide cleavage by
Ile19 mutants (conditions as in panel C). Values shown in panels C and D are
averages (n=3); error bars represent one standard deviation.
We used trypsin to probe effects of the helix-A alanine-substitution mutations on the
conformation of the ClpP channel, which contains potential sites of tryptic cleavage after
Arg 2 and Arg15. Incubation of trypsin with a wild-type ClpP variant bearing a C-terminal
His6-tag resulted in formation of a stably truncated fragment within 30 minutes, as assayed
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by SDS PAGE (Figure 5A). Control experiments with ClpP lacking a His6-tag revealed that
tryptic cleavage removed this C-terminal affinity tag (data not shown). The Y20A, S21A,
R22A, L23A, and K25A mutants behaved like the wild-type control after incubation with
trypsin (Figure 5A). By contrast, the I19A and L24A mutations resulted in enhanced trypsin
susceptibility, as shown by lower molecular weight products following SDS PAGE (Figure
5A). Edman sequencing of these smaller fragments revealed that the 119A mutant was
cleaved after Arg12, whereas the L24A mutant was cleaved after Arg'15 (data not shown).
Thus, the 119A and L24A mutations, which resulted in the largest increases in decapeptide
cleavage, also increase the susceptibility of the N-terminal ClpP channel to tryptic cleavage.
These results support a model in which packing interactions mediated by the wild-type side
chains of Ile 19 and Leu24 stabilize a stem-loop conformation of the N-terminal channel that
restricts passage of all but the smallest peptides into free ClpP.
If the helix-A mutations increase decapeptide-cleavage activity solely by influencing the
conformation of the ClpP channel and pore, then the effects of a double mutation involving
helix A and the channel should not be additive. Indeed, when we constructed and purified an
L24A/GGGGGGGG' 15 variant of ClpP, this double mutant was no more active in cleaving
the decapeptide than the parental L24A or GGGGGGGG 15 mutants (Figure 5B). These
results strongly suggest that mutations in both helix A and in the ClpP channel disrupt local
conformations that are required to restrict diffusive passage of the decapeptide substrate into
the ClpP proteolytic chamber.
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Figure 5. Properties of channel-loop and helix-A mutants. (A) Analysis by SDS-
PAGE of time courses of digestion (30 oC) of wild-type CIpP14 or variants (0.7
pM) with trypsin (0.5 pM). The initial shift in mobility observed for all proteins is
caused by cleavage of the C-terminal His 6 tag. (B) Rates of decapeptide (15 iM)
cleavage by single and double ClpP mutants (4 /M tetradecamer) containing the
GGGGGGGG'15 channel-loop substitution and/or the L24A helix-A mutation.
Values are averages (n=3); error bars represent one standard deviation. (C)
Degradation of the carboxymethylated 35S-titin-I27-ssrA protein (5 MM) by wild-
type ClpP 14 or the I19A mutant (1 /M). Values are averages (n=2). The solid lines
are fits to an exponential function.
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Deletion of the N-terminal 10, 14, or 17 residues of mature ClpP allows these mutants to
degrade a-casein, a natively unfolded protein (Bewley et al. 2009). To test if a helix-A
mutation also allows ClpP to degrade unfolded proteins, we assayed degradation of a
carboxymethylated and 35S-labeled variant of the 127 domain of human titin (Kenniston et al.
2003). Indeed, this 113-residue unfolded substrate was degraded far more rapidly by I19A
ClpP than by wild-type ClpP (Figure 5C). The I19A CIpP mutant did not degrade the native
titin 127 domain (data not shown). These results show that a single amino-acid substitution
in ClpP is sufficient to deregulate gating, allowing the mutant to degrade unfolded proteins,
and highlight the important role played by I19 in controlling access to the ClpP chamber.
In studies of a ClpP mutant lacking seven N-terminal amino acids, Jennings et al. (2008)
observed non-linear cleavage kinetics of the succinyl-LY-AMC dipeptide, caused by
accumulation of an acylated enzyme intermediate. Using this substrate and their assay
conditions, our 119A and L24A ClpP mutants failed to show comparable behavior,
suggesting that accumulation of acylated ClpP is probably a consequence of the deletion
mutation used and not a general consequence of unregulated gating. Maurizi and colleagues
also showed that wild-type ClpP cleaves specific peptides with turnover numbers of ~10,000
min-1, a result inconsistent with slow hydrolysis of the acyl intermediate in peptide-bond
hydrolysis for wild-type ClpP (Thompson et al. 1994a).
Helix-A mutations disrupt ClpX binding
Deletion and substitution mutations affecting residues that form the CIpP pore and channel
have been shown to weaken or prevent ClpX binding (Kang et al. 2004; Gribun et al. 2005;
Jennings et al. 2008; Bewley et al. 2009). To test if the alanine-substitution mutations in
helix A have similar effects, we combined increasing quantities of these mutants with a
fixed concentration of ClpX and assayed for ATP-dependent degradation of GFP-ssrA. The
I19A, Y20A, S21A, R22A, and L24A mutants showed very low substrate cleavage at the
highest ClpP concentrations tested, suggesting substantial defects in ClpX binding, whereas
the L23A and K25A mutants showed only modest decreases in apparent ClpX affinity
(Figure 6A & 6B).
Importantly, the effects of helix-A mutations on ClpX interactions were relatively poorly
correlated with decapeptide cleavage or trypsin susceptibility. For the I19A and L24A
mutations, for example, all three assays showed large changes compared to the wild-type
controls. For the S21A and R22A mutations, by contrast, large effects on apparent ClpX
binding were coupled with relatively small effects on decapeptide cleavage and no changes
in trypsin susceptibility. Similarly, the L23A mutant bound ClpX (Kapp = 0.2 pM) far better
than the R22A mutant (Kapp > 10 pM), but both mutations resulted in similar rates of
decapeptide cleavage (Figure 6A). Thus, these results suggest that helix-A mutations, such
as S21A and R22A, do not affect ClpX binding solely through indirect effects on ClpP-
channel residues but also influence ClpX interactions directly.
We also combined the R22A and S21A mutants with ClpA and assayed GFP-ssrA
degradation. Interestingly, half-maximal degradation of GFP-ssrA by ClpAP required only
~6-fold higher concentrations of the R22A mutant than of wild-type ClpP and both the wild-
type and mutant complexes degraded this native substrate at similar rates under conditions
of CIpP saturation (Figure 6C). By contrast, combining the S21A mutant with ClpA resulted
in GFP-ssrA degradation at a maximal rate half that of the wild-type enzyme complex
(Figure 6D). These results suggest that the Arg22 and Ser 21 side chains of ClpP play far more
important roles in binding ClpX than in binding ClpA.
decapeptide
cleavage rate
(min-rri CIpP14. 1)
0.075
1.67
0.30
0.55
0.12
0.50
1.50
0.10
Ko for ClpX
(pM)
0.1
n.d.
19
n.d.
n.d.
0.2
n.d.
0.65
Y20A
119A, S21A
R22A, L24A
C 1.2
ZOc 0.8-
.3 0.6-
Sb 0.4-
o 0.2 -a.
D
.-
i ,
o
1.2
1.0
0.8
0.6
0.4
0.2-
0 1 2 3 4
[ClpP or variants] (pM tetradecamer)
CIpX CIpA
T I
ao- R22A d R22A
p CIpP p CIpP
CIpX CIpA
Ti
wild- wild- S21A
type CIpP typ CIpPCIP IP
Figure 6. Interaction of ClpP variants with CIpX or ClpA. (A) Decapeptide cleavage
activity of isolated ClpP or its helix-A mutants and the affinity of these enzymes for ClpX,
as measured by the GFP-ssrA degradation assays shown in panel B. n.d., affinity was too
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DISCUSSION
Previous studies demonstrated that ClpP alone has a very limited ability to degrade peptide
substrates larger than a few amino acids, but this activity can be stimulated substantially by
ClpA (Thompson et al. 1994b). The work reported here shows that ClpX binding to ClpP
also enhances its rate of polypeptide degradation. For both ClpX and ClpA, the magnitude
of the rate enhancement increases with the molecular weight of the peptide substrate and
requires ATP binding by the AAA+ enzyme but not hydrolysis. These results in
combination with crystal structures of ClpP and studies of ClpP mutants suggest that simple
ATP-dependent binding of either ClpX or ClpA to ClpP induces conformational
rearrangements that allow unfolded peptide and polypeptide substrates to diffuse through the
axial channel and into the proteolytic chamber of ClpP. Although ClpX and ClpA are both
AAA+ ATPases, they differ markedly in size, sequence, substrate specificity, and some
aspects of their interactions with ClpP (Gottesman et al. 1990; Gottesman et al. 1993; Singh
et al. 2000; Flynn et al. 2001; Kim et al. 2001; Sharma et al. 2005). Thus, their common
ability to activate ClpP peptide cleavage was not a foregone conclusion.
The majority of ClpP molecules in E. coli appear to be bound to ClpX or ClpA, but
measurements of intracellular abundance and affinity calculations suggest that some ClpP is
present as the free enzyme (Farrell et al. 2005). The inability of this uncomplexed ClpP to
degrade unstructured polypeptides is likely to be important in avoiding rogue degradation of
such sequences in the cell. For example, unstructured regions can be essential for protein
function, native and denatured proteins are often in dynamic equilibrium, and nascent
polypeptides might be degraded immediately after synthesis. Indeed, acyldepsipeptide
antibiotics kill E. coli and other strains of bacteria by activating ClpP polypeptide
degradation and preventing its binding to ClpX/ClpA (Kirstein et al. 2009). Our results
indicate that restriction of the polypeptide cleavage activity of free ClpP depends both on the
identity of residues in the wild-type channel and in the neighboring helix A.
ClpX- or ClpA-dependent remodeling of the ClpP channel is probably required to allow
efficient ATP-fueled degradation by these AAA+ proteases. Degradation of unfolded
polypeptides by ClpXP or ClpAP, which is independent of ATP hydrolysis, is a useful
biochemical assay but is likely to be biologically irrelevant. This conclusion follows from
the facts that only ATP-bound forms of ClpX or ClpA bind ClpP and that ATP hydrolysis
by these complexes is both constitutive and stimulated by substrates (Joshi et al. 2004; Sauer
et al. 2004; Hersch et al. 2005). In fact, wild-type ClpXP hydrolyzes roughly 100 ATPs
during degradation of a single molecule of the unfolded titin 127 domain (Kenniston et al.
2003).
Deletion of N-terminal sequences that form the ClpP channel has been shown to activate
polypeptide cleavage, and crystal structures of mutants lacking 14 or 17 N-terminal residues
reveal altered positions for some of the remaining pore/channel residues (Jennings et al.
2008; Bewley et al. 2009). Our results show that amino-acid substitutions in helix A (e.g.,
119A) and in the channel (e.g. AQTSAGAA 15) have similar effects to those caused by large
N-terminal deletions in terms of allowing ClpP degradation of polypeptide substrates. These
results suggest that relatively small perturbations in the structure of ClpP are sufficient to
permit more efficient polypeptide degradation. Systems of this type, in which many different
mutations lead to similar gain-of-function phenotypes, generally occur via an increase in the
population of an active conformation because a competing inactive conformation is
destabilized. For ClpP, it seems likely that "restrictive" and "permissive" conformations of
the channel are in dynamic equilibrium in the wild-type enzyme, with the permissive
conformation being present in just a small fraction of enzymes. By this model, any mutation
that destabilized the restrictive conformation would increase the population of enzymes with
permissive channels.
In the simplest allosteric model, activating ClpP mutations and the binding of ClpX or ClpA
might stabilize the same permissive ClpP conformation. In this case, however, activating
mutations should enhance binding of the AAA+ ATPases to ClpP, because less binding
energy would be required to drive the conformational change. This result is not observed.
Indeed, our work and previous studies (Bewley et al. 2009) show that activating channel
deletion and substitution mutations reduce ClpP affinity for ClpX and ClpA. Although it is
formally possible that all of the mutations that activate polypeptide cleavage by ClpP also
involve side chains that directly contact the AAA+ ATPases in the ClpXP or ClpAP
complexes, this explanation seems unlikely. The observed results could also be explained if
there were multiple "permissive" conformations of the ClpP channel and ClpX or ClpA
binding stabilized different conformations than the activating mutations. High resolution
structures of ClpP in complex with ClpX or ClpA will be needed to resolve this issue.
There is abundant evidence that ClpX and ClpA interact with ClpP channel residues. For
example, both double-mutant cycle analysis and crosslinking support the existence of
contacts between the axial pore-2 loops of ClpX and channel residues of ClpP (Martin et al.
2007). We find that certain helix-A mutations (S21A; R22A) also reduce ClpX affinity.
Although some of these helix-A effects could be indirectly caused by remodeling of channel
residues, our results are most consistent with direct effects on ClpX binding. For example,
the R22A mutation causes a larger defect in ClpX binding than ClpA binding, activates ClpP
polypeptide cleavage only modestly, and does not alter the sensitivity of ClpP channel
residues to tryptic cleavage. In the ClpP structure, helix A connects the pore and channel
residues to residues that form the hydrophobic clefts, which serve as docking sites for the
IGF/IGL motifs of ClpX and ClpA. It remains to be determined if these docking interactions
transmit a signal via helix A that remodels the channel residues of ClpP or if other binding
interactions are responsible for this activity. In this regard, interactions between the pore-2
loops of ClpX and ClpP are not required for activation of polypeptide cleavage (Martin et al.
2007).
Our results show that changes in the sequence of the ClpP channel prevent translocation of
certain highly charged sequences during ATP-dependent degradation by ClpXP.
Specifically, replacing Glu8 , Arg12 , Glu 14 , and Arg'5 in the wild-type ClpP channel with
alanines resulted in a mutant, which in combination with ClpX, could degrade ssrA-tagged
peptides with stretches of non-polar residues (FGFGFGFGFG) but could not degrade
otherwise identical peptides containing runs of glutamic acids, lysines, or glcines. These
findings suggest that the wild-type ClpP channel facilitates translocation of diverse
sequences, including highly charged amino acids, during normal ClpXP degradation. It is
unlikely that such an activity would be required if the channel dimensions were wide enough
to allow efficient solvation of the translocating polypeptide. Because the residues
corresponding to Glu 8, Argl2, Glu1 4 , and Arg 15 in E. coli ClpP are highly conserved in
orthologs, one function of these side chains may be to neutralize charges on translocating
polypeptides. Thus, the channel of ClpP appears to play an active rather than passive role in
energy dependent degradation.
MATERIALS AND METHODS
Proteins and peptides
The E. coli ClpP variants used in these studies had C-terminal His 6 tags (Kim et al. 2000),
were generated by inverse PCR mutagenesis, and were expressed from multi-copy, IPTG-
inducible pQE70 vectors, and purified as described by Kim et al. (2000). Mutant names
refer to the altered amino-acid position(s) in the mature form of E. coli ClpP. Wild-type E.
coli ClpX, ClpXE185Q, and covalently linked wild-type ClpX trimers lacking the N-domain
were expressed and purified as described (Kenniston et al. 2003; Hersch et al. 2005; Martin
et al. 2005).
Succinyl-LY-AMC was purchased from Sigma. The Abz-KASPVSLGYN02D decapeptide
(where Abz is the fluorophore 2-aminobenzoic acid and yNO2 is the quencher 3-nitrotyrosine)
was a gift from B. Cezairliyan (MIT). The 20-mer peptide, Abz-
ASSHATRQLSGLKIHSNLYNO2H, was a gift from Eyal Gur (MIT). SsrA-tagged peptides
were gifts from Igor Levchenko and Sarah Barkow (MIT). Each peptide consisted of an N-
terminal cleavage module (Abz-FAPHMALVPYNO2), a guest region ([YG] 5, [FG] 5, [E 1],
[Rio], [K 1o], [Qo1], [A6], [Ps] or [G4]) and a C-terminal sequence (KKANDENYALAA)
containing the ssrA tag (Barkow et al. 2009). GFP-ssrA was purifed as described (Burton et
al. 2001). E. coli SspB was a gift from S. Barkow (MIT).
Assays
Degradation assays were performed at 30 'C in PD buffer, which consists of 25 mM Hepes
(pH 7.6), 100 mM KCI, 20 mM MgCl 2, 1 mM EDTA, and 10% glycerol, and were generally
monitored by changes in fluorescence using a QM-2000-4SE spectrofluorimeter (Photon
Technology International). When ClpX was present in assays, it was was preincubated with
1 mM nucleotide (ATP, ATPyS, or ADP) for at least 1 minute prior to addition of ClpP and
substrate. Succinyl-LY-AMC cleavage assays (excitation 345 nm; emission 440 nm)
contained 50 [tM substrate and 0.1 tM ClpP 14 with or without 1 uM ClpX6 . Decapeptide
cleavage assays (excitation 320 nm; emission 420 nM) contained 15 tM substrate and 0.3
/iM ClpP 14 with or without 0.5 pM ClpX 6. Degradation of the 20-mer peptide (excitation
320 nm; emission 420 nM) was assayed using 15 yM substrate and 0.1 pM ClpP14 with 1
mM ATPyS, plus or minus 0.5 yM ClpX 6. The assays described above used peptide
substrate concentrations substantially below KM for degradation by ClpP 14 , as shown by
linear changes in rate versus substrate concentration plots. Degradation of ssrA-tagged
peptides (excitation 320 nm; emission 420 nm) was assayed using 8 pM substrate, 8 pM E.
coli SspB, 4 yM ClpP 14, 0.15 pM ClpX6, and an ATP regeneration mix (Kenniston et al.
2003). Control experiments lacking ClpX were performed to test background peptide
degradation by free ClpP. Under these conditions, the substrate concentration is well above
K,. For GFP-ssrA degradation assays (excitation 467 nm; emission 511 nm), each reaction
contained 5 pM substrate (KM 1-2 pM), a covalently linked ClpX-AN trimer (0.1 pM
pseudo-hexamer equivalents) or ClpA6 (50 nM), an ATP regeneration mix, and increasing
concentrations of ClpP or ClpP mutants. For ClpX-independent degradation of the unfolded
protein, carboxymethylated [35S]-titin-I27-ssrA, 5 iM substrate was incubated with 1 tM
ClpP14 or I19A-ClpP 14 and degradation was monitored by the release of acid-soluble
peptides (Kenniston et al. 2003).
Active-site modification of ClpP 14 (0.5 /M) with rhodamine-FP (200 pM; a gift of B.
Cravatt, Scripps) was performed in PD buffer at 00 C with or without ClpX 6 (1 pM), ADP (5
yM), or ATPyS (5 /M). Reactions were quenched in 2% SDS, separated by SDS-PAGE on
12% gels, and fluorescently modified ClpP was quantified using a Typhoon fluorimager and
ImageQuant software. Tryptic digests were performed in PD buffer at 30 oC using wild-type
or mutant ClpP 14 (0.7 yM) and porcine pancreas trypsin (0.5 yM; Sigma). At different times,
reactions were quenched by boiling in 2% SDS and 1 mM phenylmethanesulphonyl
fluoride, and aliquots were subjected to 12% SDS-PAGE and then stained with Coomassie
Blue.
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CHAPTER THREE:
Dominant Negative Selection for ClpP Mutants that Prevent Degradation
of an ssrA-tagged Substrate by ClpXP
INTRODUCTION
The proteolytic complex formed by ClpX and ClpP represents an important example in
which two large protein machines must work together to ensure the selective degradation of
target proteins. To probe determinants in ClpP that are important for its collaborative
function with ClpX, I carried out a genetic selection for dominant negative ClpP mutations
that prevented ClpXP degradation of an ssrA-tagged protein substrate.
ClpP serves as a good model system in which to try to understand the structural and
functional features that are required for the activity of a compartmental peptidase. The
crystal structure of this homo-tetradecameric serine protease has been solved by itself
(Wang et al. 1997; Bewley et al. 2006), in an inhibitor-bound state (Szyk et al. 2006), and in
a peptide-bound state (Kim et al. 2008). Numerous studies of peptide and protein
degradation by ClpP and ClpXP have also been reported (Thompson et al. 1994; Gottesman
et al. 1998; Sauer et al. 2004). Although there are no high-resolution structures of the
ClpXP complex, recent structures of the AAA+ ClpX hexamer in nucleotide-free and
nucleotide-bound conformations provide some insight into the molecular motions that may
be involved in substrate unfolding and translocation (Glynn et al. 2009).
Biochemical studies suggest that communication between ClpX and ClpP occurs
bidirectionally. For human ClpXP, assembly of the complete ClpP tetradecamer from two
heptameric rings requires the presence of ClpX (Kang et al. 2005). Thus, binding of a ClpX
hexamer to one face of a heptameric ClpP ring appears to alter ClpP*ClpP interactions on
the opposing face of the ring. For E. coli ClpXP, formation of the complex results in a
slowing of the rate of ATP hydrolysis by ClpX (Joshi et al. 2004). In addition, ClpXP
complex formation increases the rate at which model peptides are cleaved by ClpP. DFP-
modified ClpP, which is thought to mimic the acyl intermediate in peptide-bond hydrolysis,
binds ClpX more tightly than unmodified ClpP (Joshi et al. 2004). Furthermore, ClpXP
affinity changes in a substrate-dependent fashion that appears to be linked to the rate at
which ClpX hydrolyzes ATP during protein unfolding and translocation. Thus,
communication between ClpX and ClpP begins upon complex formation, occurs in a
dynamic and substrate-specific fashion, and is mediated by a symmetry mismatched
interface.
Crystal structures of ClpP in which the active sites are modified by a chloromethylketone
(CMK) or with peptides bound in the active sites show subtle structural variations when
compared to the free enzyme (Szyk et al. 2006; Kim et al. 2008). The most striking
difference between these structures and free ClpP is a narrowing of the diameter of the
degradation chamber by -1.5 A. These results suggest that substrate binding stabilizes the
active sites of ClpP in a conformation competent to perform peptide-hydrolysis chemistry
(Szyk et al. 2006; Kim et al. 2008). Experiments showing positive cooperativity in the
degradation of small peptides by ClpP support this model (Thompson et al. 1994).
The CMK-modified and peptide-bound structures of ClpP provide additional insights
concerning the selectivity and processivity of polypeptide degradation. The P1 binding
pocket for the S side chain of the substrate is larger in ClpP than in many other serine
proteases (e.g., chymotrypsin and subtilisin), explaining why ClpP can accommodate
residues ranging from glycine to tyrosine at this position. Short bound peptides form the
third strand of an anti-parallel P3 sheet with strands 32' and 36 of ClpP (Kim et al. 2008).
Extending these peptides by molecular modeling suggests that longer polypeptides might
wrap around the interior of the degradation lumen with 6-8 extended amino acids spanning
the -25 A spacing between active sites. This "molecular ruler" binding mode in
combination with broad cleavage specificity may explain why ClpP cleavage of
polypeptides with completely different sequences generates nearly identical distributions of
products in terms of peptide length (Choi et al. 2005).
Almost all mutagenesis of ClpP reported to date has been based on the crystal structure
(Kang et al. 2004; Gribun et al. 2005; Bewley et al. 2006; Bewley et al. 2009). I wished to
probe the sequence determinants of ClpP and ClpXP activity in a less-biased fashion by
selecting for ClpP variants whose overexpression, in the presence of wild-type ClpX and
ClpP, could prevent efficient degradation of an ssrA-tagged substrate in vivo. Dominant-
negative mutants of this type should be capable of folding and forming tetradecamers and
thus any defects should affect other aspects of ClpP function required for ClpXP proteolysis.
RESULTS AND DISCUSSION
Selection Strategy
To identify residues of ClpP required for function with ClpX, I designed a genetic system in
which a protein with a selectable function would only be present at high steady-state levels
in vivo if it was not degraded by ClpXP. For the selectable protein, I chose chloramphenicol
acetyl transferase (CAT), which mediates resistance to the antibiotic chloramphenicol and
assembles into a trimeric enzyme with unstructured C-terminal tails (Leslie 1990). To make
this enzyme a substrate for ClpXP degradation, I fused its coding sequence to a sequence
encoding a C-terminal ssrA to generate a CATssrA gene.
Pconstitutive
ybhD F I CATssrA ybhH
randomized
cdpP library
clpX+ clpA+ clpP+
Figure 1. Strategy used to select for dominant-negative ClpP mutants.
CATssrA is constitutively expressed but degraded by ClpXP in an otherwise
wild-type E. coli strain. Following introduction of a randomized clpP*
library under arabinose-promoter control, dominant-negative ClpP* variants
should inactivate ClpXP and prevent CATssrA degradation, resulting in
chloramphenicol resistance.
The gene encoding CATssrA was placed under transcriptional control of a synthetic
constitutive promoter (Jensen et al. 1998) and was integrated between two non-essential
genes, ybhD and ybhH, in the E. coli chromosome. When this CATssrA strain also harbored
wild-type copies of the clpX, clpA, and clpP genes, cells were killed by addition of
chloramphenicol (Figure 2A). When the genes for either clpX or clpP were deleted,
however, the CATssrA strain became resistant to chloramphenicol (Figure 2A). These
results suggest that CATssrA is synthesized efficiently but is degraded in a clpX- and clpP-
dependent fashion (Figure 2A). Importantly, deletion of clpA did not confer
chloramphenicol resistance to the CATssrA strain. Although ClpAP degrades ssrA-tagged
proteins in vitro, the presence of the SspB and ClpS adaptor proteins appear to repress
ClpAP degradation of such substrates in vivo (Gottesman et al. 1998; Farrell et al. 2005;
Lies et al. 2008). Taken together, these results are consisent with a model in which ClpXP
is responsible for the in vivo degradation of CATssrA.
To confirm that CATssrA was degraded in a ClpP-dependent reaction, I monitored
CATssrA protein levels in a AclpP strain in which a His 6-tagged ClpP variant could be
expressed in an arabinose-dependent fashion (Figure 2B). In a mock induction without
arabinose (Figure 2B, left panel), no accumulation of ClpP-His 6 was detected as determined
by a Western blot probed with an a-His6 antibody, but CATssrA (which has an internal His 6
tag) accumulated. Following addition of arabinose (Figure 2B, right panel), CATssrA levels
were undetectable 20 minutes after induction. Thus, CATssrA appears to be efficiently
degraded in a reaction mediated by ClpP.
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Figure 2. (A) CATssrA strains in which clpX or clpP were deleted are
resistant to chloramphenicol. Deletion of clpA did not result in
chloramphenicol resistance. Spot tests are 10-fold serial dilutions, with the
most concentrated samples on the left. (B) In a clpP-deletion strain,
Western blots using anti-His6 antibodies show that CATssrA (internal Hiss6
tag) accumulates when ClpP-His 6 is absent but does not accumulate when
ClpP-His6 is expressed from an arabinose-inducible promoter. The
numbers above each lane are times, in minutes, following a mock induction
or the addition of 0.2% arabinose.
Selection Results
A randomized library of clpP mutants on a low-copy plasmid vector was generated by error-
prone PCR. The total libray size was 1.7 x 106, and sequencing of selected variants revealed
an average of -1 mutation per clpP gene. Following addition of 0.2% arabinose, Western
blots showed that plasmid-expressed ClpP levels were 6-10 times higher than levels from
the chromosomal gene (data not shown). I selected for dominant-negative ClpP* mutants by
growth in the presence of chloramphenicol. To confirm that the drug-resistant phenotypes
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arose from mutant ClpPs, plasmids were purified after the initial selection, retransformed
into fresh selection strains, and reselected on LB-chloramphenicol plates. Each clone was
also tested to ensure that the chloramphenicol-resistance phenotype was arabinose-
dependent.
My selection identified 52 unique clpP* variants. Of these variants, 37 contained single
mutations and 15 contained multiple mutations. Table 1 lists the single mutations and
indicates their anticipated contribution to ClpP function. The majority of single mutations
mapped to one of five ClpP areas: the N-terminal channel and pore, ca-helix A, the
hydrophobic clefts, the ring-ring interface, and the catalytic triad and substrate-binding
region. Table 2 lists the amino-acid substitutions in clpP* variants with multiple mutations.
Residue Functional Consequence I Conservation Consensus (%)I
M39K unknown Met (39)
Q46R unknown 10 Gin (95)
E51G unknown 4 Glu (71)
S75F unknown 8 Ala (73)
S75P unknown 8 Ala (73)
T791 unknown 10 Thr (95)
S97P Active Site 10 Ser (99)
M120T unknown 9 Met (84)
123R* Active Site 11 Gln (100)
P124S* Active Site 10 Pro (97)
E141K Active Site 4 Glu (70)
E141G Active Site 4 Glu (70)
L143P Active Site 5 Leu (78)
L152P unknown 8 lie (53)
D1 67G iinknown Acn (4)
D1 71G Active Site
F173L unknown
F1 73V unknown
10 Asp (98)
7 Phe (70)
7 Phe (70)
Table 1. Single dominant negative mutations in ClpP. Conservation scores, consensus
identity, and % were derived from a multiple sequence alignment of bacterial ClpP proteins
(Waterhouse et al. 2009). Colors indicated likely functional significance. Mutants denoted
by an asterisk are involved in both ring-ring interactions and the active sites.
~ . .. . . .-- .. ............. . . . . . . . . . .
Mutations
1 P4Q, Q129R
2 E8K, 163V, T79A, E181G
3 E14G, 119T, Q123K
4 K25M, 1142V
5 M39L, E51 G
6 L42R, S160L
7 163V, D167N
8 F82L, T133S
9 Q94R, N150D
10 K108E, 1137S, K144R
11 Y128C, L152P
12 1135T, V185A, T190A
13 E136G, L203P
14 1137N, T157A
15 1188G, K144E
Table 2. Non-single site mutants of ClpP identified in
the dominant negative selection.
N-terminal Mutations
As discussed in chapter 2, crystallographic and mutagenesis studies have suggested
important roles for N-terminal ClpP residues in forming the channel and pore into the
degradation chamber and in binding ClpX and/or ClpA (Kang et al. 2004; Bewley et al.
2006; Bewley et al. 2009). I recovered the P4R, V6A, and V6G substitutions in my
selection for dominant-negative mutations (Table 1). In the ClpP structure, Pro4 and Val6
form part of the stem region of the channel pore and pack together in a conserved
hydrophobic cluster with Ile 19, Leu24, and Phe49. Bewley et al. (2006) previously showed
that the P4A and V6A mutations caused aberrant processing of the ClpP propeptide,
eliminated detectable cleavage of casein by ClpP alone, and showed no detectable
interactions with ClpX. Nevertheless, the purified P4A and V6A mutants showed normal
cleavage of a model dipeptide, and the V6A crystal structure revealed a 14-mer with well-
formed active sites but with rearrangements in the only portion of the channel visible in
electron-density maps (residues 15-17; Bewley et al. 2006).
In principle, dominant negative ClpP mutants could act in two ways: (i) 14-mers formed just
by mutant subunits could bind ClpX in an inactive complex and thus prevent formation of
wild-type ClpXP complexes; or (ii) wild-type and mutant subunits could assemble into
mixed 14-mers that were unable to bind ClpX or formed inactive complexes with ClpX.
Because a 14-mer formed just with P4A or V6A subunits failed to bind ClpX (Bewley et al.
2006), it seems likely that the dominant-negative phenotype of the P4R, V6A, and V6G
mutants results from formation of mixed multimers with wild-type ClpP subunits.
Helix-A Mutations
In Chapter 2, I showed that mutations in helix A affected gating through the axial pore and
ClpX binding. I isolated three dominant-negative mutations (I19T, S21Y, and S21P) in
helix A (Table 1). The purified I19T mutant had biochemical properties similar to the I19A
and I19V mutants characterized in Chapter 2. Specifically, I19T ClpP had no defects
processing its propeptide fragment (as confirmed by mass spectrometry; not shown) and had
trypsin-accessible N-termini (Figure 2A). In addition, I19T ClpP showed -15-fold faster
cleavage of a decapeptide (Figure 2B) than wild-type ClpP and also independently degraded
carboxymethylated titin, an unfolded protein substrate (Figure 2C). I19T ClpP also showed
defects in ClpX interactions, as this mutant failed to alter the ATPase rate of ClpX (Figure
2D). I did not purify the S21Y or S21P variants but suspect that these mutants (like S21A)
would also show defects in gating and in ClpX binding. Similar to mutations in the N-
terminal stem loop, it seems likely that the dominant-negative phenotypes of the helix-A
mutations are caused by mixed multimer formation with wild-type ClpP.
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Figure 3. Comparative activities of wild type and I119T ClpP. (A) Limited
tryptic digests, (B) decapeptide cleavage activity, (C) degradation
carboxymethylated 0-127, and (D) ClpX ATPase response to ClpP.
Hydrophobic-cleft Mutations
The IGF loops of ClpX are thought to dock into hydrophobic clefts on the periphery of the
ClpP ring (Kim et al. 2001). Figure 4A shows a surface representation of a ClpP ring with
cleft residues colored in purple and blue. Four single dominant-negative mutations affected
residues in or near the cleft (V28P, L48P, L 114P, L 114R; Table 1). Another cleft mutation
I ~a -- ~I - ~- II 5 c--
(F82L; Table 2) was recovered with one additional mutation (T133S), which is likely to be
silent based on phylogenetic comparisons.
I purified the V28P mutant from a clpP-deletion strain and found that it was properly
processed as determined by mass spectrometry (data not shown). Thus, this mutant must be
active in autoprocessing of the 14-residue propeptide. In addition, the purified V28P
enzyme degraded a decapeptide at approximately 60% of the wild-type ClpP rate (Figure
4B), showing that it is catalytically active. These assays indicate the V28P mutant is
properly folded. I detected no interaction between V28P ClpP and ClpX in pull-down
assays (not shown) and observed a very weak interaction in ClpX- and nucleotide-dependent
stimulation of decapeptide cleavage (Figure 4C). Moreover, I did not detect any degradation
of GFP-ssrA when ClpX was combined with the V28P mutant (data not shown). To test for
potential degradation in vivo, I monitored CATssrA protein levels in a clpX' AclpP strain
transformed with a plasmid encoding V28P ClpP. As shown in Figure 4D, roughly
comparable amounts of CATssrA accumulated in the absence of V28P ClpP and when
expression of this mutant was induced by addition of arabinose. These combined results
indicate that the major effect of the V28P mutation is a substantial decrease in its affinity for
ClpX.
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Figure 4. (A) Location of Va128 (blue) on a surface depiction of a ClpP ring
(PDB 1YG6). Residues L48, Y60, Y62, F82, 190, M92, F112, L114, and L189
of the hydrophobic cleft are colored purple. (B) Activity of wild-type ClpP and
the V28P mutant in cleavage of the Abz-KASPVSLGYN0 2D decapeptide. (C)
Activation of V28P decapeptide cleavage by ClpX occurs with ATPyS
(triangles) but not ADP (squares). ClpX stimulation of wild-type ClpP (circles)
was performed with ATPyS. (C) Western blots show that CATssrA
accumulates to roughly similar levels in vivo in the absence of V28P ClpP and
following arabinose-mediated overexpression of this mutant (for comparison,
see Figure 2B).
Only one cleft mutation (F112A) has previously been characterized biochemically. Bewley
et al. (2006) reported that this mutation prevented interactions with ClpX, but I found that
the F112A mutant behaved similarly to wild type ClpP in ClpX-interaction assays
(Appendix B). Nevertheless, the biochemical properties of the V28P mutant and the
recovery of several different dominant-negative cleft mutations suggest that these amino-
............... .
acid substitutions inactivate wild-type ClpP by formation of mixed oligomers, which bind
ClpX very poorly.
Ring-ring Interface Mutations
Nine of the single dominant-negative mutants (G126S, Q129R, G130D, D134G, D134N,
I135T, I137T, K144E, and E169K; Table 1) altered residues in or near the interface between
the two heptameric rings of ClpP. I attempted to purify the D134G mutant but it had very
low solubility and I did not obtain pure protein. I suspect that the mutant subunits in this
class interact with wild-type subunits to form single heptameric rings, which cannot then
assemble into stable tetradecamers. Single rings of human ClpP are poorly active in peptide
cleavage and require the presence of ClpX to form stable tetradecamers (Kang et al. 2005).
Thus, some ClpX binding energy must be used to drive conformational changes that allow
stable ring-ring interactions. If mixed heptamers containing wild-type and mutant subunits
of E. coli ClpP cannot form tetradecamers, then ClpX may be unable to bind or ClpX6ClpP 7
complexes may be proteolytically inactive. If ClpX 6ClpP7 complexes assembled and had
unregulated proteolytic activity, I would have expected mutants in this class to display
expression-linked growth defects but none were observed.
Active-site Mutations
Seven of the dominant negative mutations (S97P, Q123R, P124S, E141K, E141G, L143P,
and D171G; Table 1) altered residues in the catalytic triad or in the substrate-binding pocket.
Previous studies have shown that the S97A ClpP mutant, which removes the active-site
serine, binds ClpX and can trap intact substrates in its chamber (Flynn et al. 2003; Joshi et
al. 2004). I argued above that the dominant-negative phenotypes of other classes of mutants
must arise because of formation of mixed multimers with wild-type subunits. Thus, it seems
unlikely that the active-site mutants are dominant because they form homo-tetradecamers
that compete with wild-type tetradecamers for ClpX binding. However, formation of 14-
mers containing a mixture of wild-type subunits and subunits with active-site mutations
would still have some wild-type active sites. Why then would these enzymes be inactive?
One possibility is that these mutations cause subtle changes in ClpP folding that are
propagated to and inactivate the wild-type active sites. Another possibility is that mixed
tetradecamers in combination with ClpX do cleave substrates but at a rate that is too slow to
remove CATssrA efficiently from cells. In support of this model, Thompson et al. (1994)
showed that ClpP enzymes in which most active sites were modified with DFP cleaved
substrates more slowly and released higher molecular weight products than the wild-type
enzyme. Nevertheless, further studies will be needed to clarify the mechanism by which
active-site mutations result in a dominant-negative phenotype.
Unclassified Mutations
Eleven mutations (M39K, Q46R, E51G, S75F, S75P, T79I, M120T, L152P, D167G, F173L,
and F173V; Table 1) could not be easily classified and affected side chains that were
generally buried within individual ClpP subunits. In mixed multimers with wild-type
subunits, these mutant subunits may cause changes in folding that inactivate the good
subunits or act in a fashion like that suggested above for the active-site mutants. Attempts to
purify S75P ClpP yielded low concentrations of soluble protein, supporting the hypothesis
that, at least this mutant, simultaneously was defective in ClpP folding and inactivated wild
type ClpP.
Future Studies
The selection described in this chapter identified numerous single substitution mutations in
ClpP that inhibit the ability of wild-type ClpP to collaborate with ClpX in degradation of an
ssrA-tagged substrate. Based on biochemical characterization of a few mutants and
mapping of the positions of other mutations onto the wild-type structure, plausible
mechanisms of inactivation exist for mutations that affect the N-terminal channel, helix A,
and the hydrophobic cleft. Namely, mixed tetradecamers of these mutants and wild-type
ClpP would be expected to bind poorly to ClpX. For mutations that affect residues in or
near the ring-ring interface of ClpP, it also seems reasonable that the mutant subunits would
sequester wild-type subunits into inactive heptameric rings. Nevertheless, it will be
important to test this model directly by characterizing the oligomeric state of interface
mutants. It is also possible, for example, that mutants in this class might form tetradecamers
but be impaired in other functions such as peptide egress, as some studies suggest that
cleavage products exit the ClpP degradation chamber through transient openings in the
interface region (Gribun et al. 2005).
It is less clear how mutations that affect active-site or peptide-binding residues in ClpP give
rise to the observed dominant negative phenotypes. One possibility is that mixed multimers
of these mutant subunits with wild-type subunits simply have a level of activity that is too
low to effectively remove CATssrA from cells. If this model is correct, then cells
expressing these mutants may have higher levels of CATssA, which could be detected by
Western blots or by improved growth in the presence of low concentrations of
chloramphenicol. Alternatively, allowing wild-type and an excess of mutant ClpP subunits
to exchange in vitro could reveal if mixed multimers have any detectable activity.
MATERIALS AND METHODS
Strain construction. Strains were derivatives of E. coli X90 [F'laclac'pro'/ara A(lac-pro)
nalA argE(am) rifthi-1]. Chromosomal insertions of CATssrA were constructed by genetic
recombineering (Sawitzke et al. 2007). A synthetic constitutive promoter, cp25 (Jensen et
al. 1998), was fused by PCR to a gene encoding chloramphenicol acetyl transferase gene
followed by a two residue Leu-Arg, a His6 sequence, and the ssrA tag to generate the
CATssrA gene. CATssrA was initially cloned upstream of a kanamycin-resistance cassette
in a modified pBluescript vector described in Farrell et al. (2005). Integration events were
selected by kanamycin resistance, confirmed by colony PCR, and the kan marker was then
removed using FLP recombinase (Sawitzke et al. 2007). All deletion strains were
constructed by phage P1 transduction from donor strains X90 clpA::kan, X90 clpP::kan, or
X90 clpX..kan. Knockouts were confirmed by colony PCR and western blotting using
antibodies against ClpX, ClpP, or ClpA. Deletion strains were screened for
chloramphenicol resistance by spotting 10-fold dilutions of saturated cultures onto LB plates
with or without 68 tg mL-1 chloramphenicol.
Determination of protein levels by western blot. Anti-His6 western blots were performed to
monitor the cellular amounts of CATssrA and ClpP-His6 in whole cell lysates using the
protocol described by Farrell et al. (2005).
Selection. A randomized clpP library was generated by error-prone PCR using Taq
polymerase in 20 mM Tris-HC1, pH 8.8, 10 mM KC1, 10 mM (NH4)2SO 4 , 0.1% Triton-X100
with 4 mM MgCl 2, and 0.25 mM MnCl2. (Cadwell et al. 1994). The amplified library was
cloned into a modified pBAD vector (TetR; pBR322 ori) with XhoI/NcoI cleavage sites.
The plasmid library was purified by the maxiprep method after initial amplification by
transformation into X90 cells and selection in liquid LB broth containing tetracycline (12 itg
mL-1). The frequency of mutagenesis was determined by sequencing the clpP genes of
randomly selected 15 colonies. For the selection, ten 30- tL aliquots of electrocompetent
ML183 (X90 CATssrA) were transformed with the mutagenic library, allowed to recover
and express tetracycline-resistance for 1 hour at 37 'C, and plated onto LB agar plates
containing 0.2% arabinose, tetracycline, and chloramphenicol. All colonies were picked and
screened on LB agar with tetracycline and chloramphenicol in the presence or absence of
0.2% arabinose to ensure all phenotypes were dependent on expression of the mutagenic
clpP*. Colonies were also purified and retransformed into fresh ML 183 cells and plated on
LB agar containing arabinose, tetracycline, and chloramphenicol. All clones with arabinose-
dependent and plasmid-dependent phenotypes were sequenced.
Biochemistry. 119T and V28P ClpP were expressed in JK10O (BL21 XDE3 AclpP) cells and
purified as described in chapter 2. Limited tryptic digests of ClpP, degradation of the Abz-
KASPVSLGYN 2D decapeptide by ClpP alone or with ClpX*ATPyS or ClpX*ADP, and
ClpX ATPase assays were performed as described in Chapter 2. Carboxymethylated XO-I27
was purified and unfolded as described (Kenniston et al. 2003). Degradation reactions were
performed as described in chapter 2 using 40 tM XO-I27 and 10 tM ClpP.
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APPENDIX A:
Selection for ClpX Variants that Suppress Loss-of-Function S21A ClpP
INTRODUCTION
In Chapter 2, I showed that mutations in ca-helix A of ClpP affected substrate gating and
interactions with ClpX. The S21A mutation in a-helix A was particularly interesting
because this substitution impaired binding to both ClpX and ClpA. The S21Y and S21P
mutations were also identified in the dominant negative selection described in Chapter 3,
further underscoring the importance of serine 21 for ClpP function in collaboration with
ClpX. This residue is highly conserved in multiple sequence alignments of ClpP orthologs
and interacts within the N-terminal loop from a neighboring subunit, in one crystal structure
in which the N termini of ClpP are ordered (Bewley et al. 2006). I did not detect enhanced
susceptibility of the S21A mutant to tryptic cleavage and this variant showed only a modest
increase in decapeptide cleavage when compared with wild-type ClpP.
In principle, serine 21 could interact directly with ClpX. Docking of the structures of ClpX
and ClpP did not reveal any obvious interactions, but the IGF and pore-2 loops of ClpX are
largely disordered in the crystal structure and thus it is difficult to be confident of these
model building results. To identify potential contacts between ClpP and ClpX, I designed a
selection for suppressor mutations in ClpX that would it allow to function with the S21A
ClpP mutant.
SELECTION STRATEGY
My selection for suppressor mutants used an ssrA-tagged mutant variant of the
phenylalanyl-tRNA synthetase a subunit (mPheS) as a counter selectable marker (Figure 1).
The mPheS gene encodes the A294G mutation, which broadens the substrate specificity and
100
allows the mutant enzyme to charge cognate tRNAs with para-chloro-phenylalanine and
para-bromo-phenylalanine (Kast 1994). By contrast, wild-type PheS can only charge
tRNAs with phenylalanine or para-fluoro-phenylalanine. Expression of the mPheS enzyme
in the presence of para-chloro-phenylalanine (p-Cl-Phe) leads to cell death, probably
because incorporation of this amino-acid analog into proteins results in folding defects.
Thus, degradation of mPheS-ssrA by a ClpX suppressor mutant and S21A ClpP should
allow cell growth on selective media containing p-Cl-Phe. To identify ClpX mutations that
functioned only with the mutant ClpP, I knocked out the endogenous clpP gene and replaced
it with a gene encoding the clpPS21A mutation. This integration maintained the 5' and 3'
sequences flanking the wild-type gene, and thus ClpPS21A is expressed using the native
promoter and ribosome-binding site. To prevent complications caused by mixed
oligomerization, I also knocked out the endogenous clpX gene in the selection strain.
Pconstitutive
ybhD f mPheS-ssrA vbhH
9- -,
I clppS21A
clpX cpA
Figure 1. Strategy to identify mutants of ClpX that can operate with S21A
ClpP to degrade mPheS-ssrA.
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RESULTS AND DISCUSSION
I performed control experiments to ensure that the mutant mPheS-ssrA protein was
expressed. As depicted in Figure 2, an E. coli strain (X90) carrying the mPheS-ssrA and
wild-type clpP and clpX alleles grew, although slowly, in the presence of 20 mM p-Cl-Phe.
Cells lacking mPheS-ssrA also grow slowly under these conditions (not shown). When the
mPheS-ssrA strain also harbored a clpP deletion, no growth was observed in the presence of
p-Cl-Phe (Figure 2). These results suggest that degradation of mPheS-ssrA by ClpXP is
required for survival in the presence of p-Cl-Phe. As expected, I also observed no growth of
a strain containing clpPS21A rather than wild-type clpP when p-Cl-Phe was present (Figure 2).
This result suggests that ClpPS21A is nonfunctional in the cell. I attempted to confirm
degradation of mPheS-ssrA in vivo by western blotting, but the signal was too weak to be
confident of the results. Deletion of clpX or clpA did not alter the growth phenotype of cells
with the clpPS21A allele.
- p-CI-Phe + p-CI-Phe
X90 mPheS-ssrA
X90AcipP mPheS-ssrA
X90 clpPS21A mPheS-ssrA
Figure 2. Growth of strains expressing mPheS-ssrA in otherwise wild type,
AclpP, or clpPS21A strains. Spots show 10-fold dilutions of strains in the
absence or presence of 20 mM p-Cl-Phe drug, with leftmost spots
containing the highest cell densities.
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In the selection strain, the chromosomal clpX gene was removed and ClpX was expressed
under the control of an arabinose promoter from a plasmid that had been mutagenized by
error-prone PCR (Figure 1). Using a plasmid library that contained an average of 3.5
mutations per clpX gene, I initially recovered ~1000 colonies that grew in the presence of p-
Cl-Phe. Of these colonies, 196 were picked at random and screened for an arabinose-
dependent phenotype. Sixteen clones displayed the required characteristics and were
sequenced. Of these, seven had ClpX protein-coding mutations, listed in Table 1, while the
remaining clones had wild-type clpX genes. It is possible that these plasmids had mutations
in other regions that resulted in overexpression of ClpX. Because growth in the presence of
p-Cl-Phe was arabinose dependent, it seems unlikely that the mPheS-ssrA allele was in some
fashion inactivated. It is formally possible, however, that the clpPS2 1A allele reverted back to
the wild type allele in the nine clones lacking mutations in ClpX.
Mutation(s) Functional Consequence
S16P N-domain
147T, 11 86T N-domain & Walker-B
V55A N-domain
A63T N-domain
E283A IGF loop
Q208R Box VI, downstream of pore-2
L41 Ostop C-terminal
Table 1. ClpX mutations that appear to suppress S21A ClpP.
Additional studies will be required to determine if the ClpX mutations listed in Table 1
actually allow these enzymes to collaborate functionally with S21A ClpP. Nevertheless,
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several of the mutations identified occur in functionally significant regions of ClpX. For
example, the I86T mutation alters the Walker-B motif, which contacts bound nucleotide and
is necessary for ATP hydrolysis. Moreover, the E283A mutation alters the IGF loop and the
Q208R mutation is proximal to the pore-2 loop. Both of these ClpX loops are known to
play roles in ClpP binding (Kim et al. 2001; Martin et al. 2007). It is tempting to speculate
that these mutations might increase ClpX affinity for S21A ClpP. It is difficult, however, to
rationalize why mutations in the N domain of ClpX might affect ClpP interactions, as
deletion of this domain does not impair ClpX activity or ClpXP proteolysis of ssrA-tagged
substrates (Martin et al. 2005). Work to purify and biochemically characterize these mutants
is ongoing.
MATERIALS AND METHODS
Genomic integration of clpPS2 1A. A two-step recombineering approach (developed by J. H.
Davis, personal communication) was used to insert the clpPS21A allele into the chromosome.
The first step involved a knockout through homologous recombination using a forward
primer (5'-CGGTA CAGCA GGTTT TTTCA ATTTT ATCCA GGAGA CGGAA-3') and
reverse primer (5'-CGCCC TGGAT AAGTA TAGCG GCACA GTTGC GCCTC TGGCA-
3') that were homologous to regions immediately flanking the clpP open-reading frame.
These primers were used to amplify a kanR-mPheS cassette and the product was transformed
into electrocompetent X90 [F'lacllac' pro'/ara A(lac-pro) nalA argE(am) ri/thi-l] cells.
Transformants resistant to kanamycin were checked by colony PCR for knock-out of the
endogenous clpP gene and a knock-in of the KanR-mPheS marker, which preserves the 5'
and 3' sequences flanking the original clpP gene. The next recombination step utilized
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identical primers to amplify clpPs21A, and the product was transformed into the
electrocompetent KanR-mPheS strain. In this step, transformants able to grow on para-
chloro-phenylalanine (Sigma) were selected. Clones obtained after each step of
recombineering were tested to confirm the expected genomic structure by colony PCR and
the presence or absence of ClpP was assayed by western blotting. The integrated clpPS21A
allele in the final strain was confirmed by genomic sequencing.
Genomic integration of mPheS-ssrA. The recombineering strategy used to integrate mPheS-
ssrA was identical to the one described in Chapter 3 (Sawitzke et al. 2007). A PCR product
containing mPheS with a C-terminal ssrA tag and kanamycin cassette flanked by FLP
recombinase recognition sites was transformed into E. coli strain X90, and integrants were
selected by resistance to kanamycin. Colony PCR and genomic sequencing confirmed the
final recombination product.
Selection strain construction. Strain ML311 (X90 clpPS21A AclpX mPheS-ssrA) was used for
the selection. The mPheS-ssrA-FLP-kanR locus was P1 transduced into X90 clpPS2 1A and
confirmed by colony PCR. After removing the kanamycin marker via FLP recombinase
activity, clpX was knocked out by P1 transduction from the donor strain X90 clpX::kanR.
This strain was confirmed by colony PCR and western blotting against ClpX to check for
clpX inactivation by insertion of the kanamycin cassette.
Selection. A library of randomized clpX genes was generated by error-prone PCR used Taq
polymerase for amplification in standard NEB Thermopol reaction buffer (20 mM Tris-HC1,
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pH 8.8, 10 mM KC1, 10 mM (NH 4)2 SO 4, 2 mM MgSO 4 0.1% Triton X-100). The library
was cloned into the modified pBAD vector described in Chapter 3 using NdeI and XhoI
restriction sites and was amplified by transformation and repurification from X90 cells. Ten
30- tL aliquots of electrocompetent ML311 were transformed with the amplified library,
allowed to recover for 1 hour at 37 'C in 1-mL LB/0.2% arabinose, and plated onto YEG
media (Wang et al. 2007) containing 20 mM para-chloro-phenylalanine, 12 tg mL-1
tetracycline, and 0.2% arabinose.
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APPENDIX B:
Biochemical Characterization of Mutants in the Hydrophobic Pocket of
ClpP: F112A ClpP and L114W ClpP
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INTRODUCTION
The first evidence that residues within the "IGF" motif of ClpX were important for
interactions with ClpP came from the 1268E and F270W point mutants, which were unable
to bind ClpP but were not impaired in ClpX unfoldase activity (Kim et al. 2001). By
docking of a model of the ClpX structure with the crystal structure of ClpP, the likely site of
interaction of these IGF residues with ClpP was identified as hydrophobic clefts on the
periphery of the ClpP ring. To date, there has been only limited biochemical evidence to
support this docking model. As an extension of the experiments with V28P ClpP, described
in Chapter 3, I mutagenized two other ClpP residues within the hydrophobic cleft: Phell2
and Leul 14. The F112A mutant was initially characterized by others and was reported to be
unable to bind ClpX (Bewley et al. 2006). I remade this mutant but found that it behaved
similarly to wild-type ClpP in all assays, including ClpXP degradation. I also constructed
and characterized the L114W ClpP mutation and found that it does not appear to interact
with ClpX.
RESULTS
F112A CIpP
Multiple sequence alignments of ClpP show that a phenylalanine is not strongly conserved
at position 112 (Figure 1). For example, the H. influenzae ClpP homolog has an alanine at
this position, whereas the human enzyme has a histidine. To test whether the E. coli protein
could accommodate alternative amino acids at position 112, I constructed and purified the
F112A mutant.
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80 100 112 114 120
I I I I lee I
Ecoli SPGGVITAGMSIYDTMQFIKPDVSTICMGQAASMGAFLLTAGAKGKRFCLPNSRVMIHQP
Bsubtilis SPGGSITAGMAIYDTMQFIKPKVSTICIGMAASMGAFLLAAGEKGKRYALPNSEVMIHQP
Hinfluenzae SPGGSVTAGMAIYDTMQFIKPDIRTLCIGQACSMGAFLLAGGTAGKRAALPNARVMIHQP
Human SPGGVVTAGLAIYDTMQYILNPICTWCVGQAASMGSLLLAAGTPGMRHSLPNSRIMIHQP
*8* :s **::*****:* : * 88 *: 88 ***::**:. * * ***::88 * s88
Figure 1. Local multiple sequence alignment of ClpP orthologs,
highlighting residues 112 and 114. The numbering is that of the mature E.
coli protein.
The purified Fll 12A mutant was highly soluble protein and cleaved the Abz-
KASPVSLGYNO2D decapeptide at rates comparable to wild type ClpP (data not shown).
Moreover, the electrophoretic mobility of F112A ClpP on SDS-PAGE was identical to the
wild-type enzyme, suggesting that proenzyme maturation for this mutant is not impaired
(data not shown). Both results indicate that the Fl 112A mutation does not impair the
peptide-cleavage function of free ClpP, as previously reported (Bewley et al. 2006). By
contrast, I did not detect impairment in the interaction of the F1 12A mutant with ClpX. As
shown in Figure 2A, this mutant repressed the rate of ATP hydrolysis by ClpX with an
apparent affinity very similar to that of the wild-type ClpP control. Similarly, the F112A
mutant and wild-type ClpP behaved almost identically when ClpX was titrated against a
constant amount of ClpP or the mutant and changes in the rate of decapeptide cleavage were
assayed (Figure 2B). Finally, I found that wild-type ClpP and the F112A mutant were
indistinguishable in ClpXP degradation of GFP-ssrA, a native protein substrate (data not
shown). Thus, F112A ClpP appears to be functionally equivalent to wild-type ClpP.
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Figure 2. Assays monitoring ClpXP binding. (A) Increasing quantities of wild-
type ClpP (circles) or F112A ClpP (squares) were titrated against a fixed quantity
of ClpX (0.1 yM hexamer) and changes in the rate of ATP hydrolysis by ClpX
were assayed. (B) Increasing quantities of ClpX were titrated against 50 nM wild-
type ClpP (circles) or F112A ClpP (squares) and the rate of degradation of the
Abz-KASPVSLGYN2D decapeptide was assayed.
L114W ClpP
Leul 14 is also part of the hydrophobic cleft of ClpP but is more highly conserved than
Phe 112 (Figure 1). I constructed and purified the L114W ClpP mutant, which I hoped might
be used to monitor ClpX*ClpP binding by changes in fluorescence. L114W ClpP was less
soluble than wild-type ClpP and the purified protein contained a significant population
(~50%) of unprocessed proenzyme (Figure 3A). In the absence of ClpX, L114W ClpP
cleaved the decapeptide substrate at a rate similar to wild-type ClpP (Figure 3B), suggesting
that the observed defect in L114W ClpP maturation does not arise because the mutation
prevents peptide cleavage. Addition of ClpX did not cause a significant increase in the rate
of decapeptide cleavage by L114W ClpP (Figure 3B). Similarly, no interaction of L114W
ClpP with ClpX was detected in assays monitored by changes in ATPase rates (Figure 3C),
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or degradation of GFP-ssrA (data not shown). These results suggest that the L114W-ClpP
variant is functional as a peptidase but is severely defective in binding ClpX.
I proenzyme
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0.4
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- + - +
WT L114W
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Figure 3. Characterization of L114W ClpP. (A) Mobility on 12% SDS-
PAGE shows that ~50% of the purified protein was not processed to the
mature enzyme. (B) Wild-type and L114W ClpP (0.2 /M) have the same
activity in cleavage of the Abz-KASPVSLGYNo2D decapeptide in the
absence of ClpX. Addition of 3 yM ClpX hexamer and ATPyS stimulates
peptide cleavage by wild-type ClpP but not by the L114W enzyme. (C)
Titration of the L114W mutant (squares) against ClpX (0.3 pM hexamer)
did not result in ATPase repression. Circles show the wild-type ClpP
control.
DISCUSSION
Mutations at positions 112 and 114 within the hydrophobic cleft of ClpP have different
effects on function depending on the assay. The F112A and L114W mutants both had
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peptide-hydrolysis activity comparable to wild-type ClpP. For the F112A mutant, there was
no defect in proenzyme processing and the protein was highly soluble. Processing of the
L114W mutant, by contrast, was incomplete and the protein was poorly soluble. This
reduced solubility may reflect the fact that roughly 50% of the subunits still contain the
MSYSGERDNFAPHM propeptide, which is reasonably hydrophobic. It is also possible
that this mutant has some type of folding defect (L114 is located at a subunit interface in the
heptameric ring), but this explanation seems unlikely because L114W had peptide-cleavage
activity comparable to wild-type ClpP. Why then is propeptide maturation compromised for
this mutant? One possibility is that normal maturation somehow involves stimulation of
activity by binding of propeptides, possibly after cleavage, in the hydrophobic clefts.
I found the F112A ClpP was essentially indistinguishable from wild-type ClpP in all of its
activities, including functional collaboration with ClpX. This result is supported by multiple
sequence alignments, which show that Phel 12 is not highly conserved. Bewley et al. (2006)
reported that F112A ClpP was severely defective in interactions with ClpA, did not support
ClpXP degradation of GFP-ssrA, and showed only modest repression of ClpX ATPase
activity. I did not assay the interaction of F112A with ClpA and do not know why my
results with ClpX differ from those of Bewley et al.
The L114W mutation resulted in a ClpP variant defective in binding ClpX. The larger
tryptophan side chain at this position may sterically occlude binding of the IGF motif in the
hydrophobic cleft. Alternatively, the presence of unprocessed propeptides on many L114W
subunits might interfere with ClpX binding in another fashion. Expressing L114W ClpP
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without its propeptide sequence and characterizing the fully mutant enzyme would help to
decide between these models. At present, I do not know if the heterogeneity of propeptide
processing for the L114W mutant is randomly distributed among subunits in each
tetradecamer or whether some heptameric rings or 14-mers are fully mature. More stringent
purification of this mutant before or after dissociation of 14-mers into individual heptameric
rings (Maurizi et al. 1998) might help decide these questions.
MATERIALS AND METHODS
Mutagenesis and purification. The F112A and L114W mutations were constructed by
inverse PCR using primers that introduced the necessary coding changes at each position.
Both mutant proteins contained C-terminal His6-tags, were expressed in strain JK10 (BL21
XDE3 AclpP), and were purified by chromatography on Ni"-NTA and monoQ columns as
described previously (Kim et al. 2000).
Assays for ClpP activity. Peptide hydrolysis assays using the fluorogenic decapeptide Abz-
KASPVSLGYNO2 D were performed as described in Chapter 2. Maturation defects were
detected by analyzing purified protein on 12% SDS-PAGE.
Assays for ClpXP activity. Activation of peptide degradation by ClpX was performed as
described in Chapter 2, using ATPyS, an ATP analog that supports ClpX binding to ClpP
but is slowly hydrolyzed. GFP-ssrA degradation and ATPase assays were also performed as
described in Chapter 2.
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